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Abstract 
Bacillithiol (BSH) is a recently discovered low molecular weight (LMW) thiol found amongst 
several Gram-positive bacteria including Bacillus anthracis, Staphylococcus aureus and 
Bacillus subtilis. It plays a fundamental role in the redox processes within the cell, in addition 
to many other functions including the detoxification of electrophiles such as methylglyoxal 
(MG). MG is a reactive dicarbonyl produced as a by-product of glycolysis. It is found to be 
toxic to the cell as it is capable of modifying macromolecules such as proteins and DNA 
causing loss of biological activity. The previously established glutathione-dependent 
glyoxalase pathway comprises of the glyoxalase I and glyoxalase II enzyme, which are 
found to serve as a major mechanism for the detoxification of MG amongst eukaryotes. 
There is speculation that BSH follows through this same pathway.  
Herein, the BSH-dependent glyoxalase pathway in B. subtilis is fully explored. The studies 
have shown a reaction between BSH and MG to occur spontaneously both in vitro and in 
vivo. Furthermore, these observations, have lead onto the discovery that, for the first time, 
BSH has shown to react with other metabolites in glycolysis. These include 
dihydroxyacetone phosphate, D-glyceraldehyde 3-phosphate and pyruvate. In each case 
they form a hemithioacetal (HTA). As a result, potentially significant concentrations of BSH 
may be sequestered in these ‘unknown thiol reservoirs’ which were not previously known 
to exist in the cell. Essentially, this raises questions regarding the true overall concentration 
of intracellular BSH. 
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F1,6-BP Fructose 1,6-bisphosphate 
F6P Fructose 6-phosphate 
G3P Glycerol 3-phosphate 
G3PD Glycerol 3-phosphate dehydrogenase 
G6P Glucose 6-phosphate 
GA3P Glyceraldehyde 3-phosphate 
GA3PD Glyceraldehyde 3-phosphate dehydrogenase 
GASH Glutathione amide 
GlcNAc-Mal N-acetylglucosamine malate 
GlcN-Ins Glucosamine-myo-inositol 
GlxI Glyoxalase I 
GlxII Glyoxalase II 
GlxIII Glyoxalase III 
GSH Glutathione 
GST Glutathione S-transferase  
GshA γ-glutamylcysteine ligase 
GshB glutathione synthetase 
GSSG GSH disulfide 
HEPES 4-(2-Hydroxyethyl)-1-piperazineethanesulfonic acid 
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HMBC Heteronuclear multi-bond correlation 
HPLC High performance liquid chromatography 
HSQC Heteronuclear single quantum coherence 
HTA Hemithioacetal 
Hz Hertz 
IT-ToF Ion-trap Time-of-flight 
J Coupling constant 
Keq Equilibrium constant 
k1 First order rate constant 
k2 Second order rate constant 
k-1 Reverse rate constant 
k2/k-1 Equilibrium constant 
LB Lysogeny broth 
LC-MS Liquid chromatography – Mass spectrometry 
LMW Low molecular weight 
mBBr Monobromobimane 
mB-SR Monobromobimane thiol conjugate 
Mca Mycothiol S-conjugate amidase 
MG Methylglyoxal 
MgsA MG synthase 
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MSH Mycothiol 
MST Mycothiol S-transferase 
NMR Nuclear magnetic resonance 
OD Optical density 
OVO Ovothiol 
PEP Phosphoenolpyruvate 
RDW Residual dry weight 
RPM Revolutions per minute 
RSH  Low molecular weight thiol 
T(SH)2  Trypanothione 
TEA Triethanolamine 
TIMs Triosephosphate isomerase 
TNB- 2-Nitro-5-thiobenzoate 
UDP-GlcNAc Uridine diphosphate-N-acetylglucosamine 
UV-vis Ultraviolet-visible 
WT Wild-type 
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1. Introduction  
 
Bacteria have colonised every niche on this planet from the soils of this earth – Bacillus 
subtilis to the intestines of mammals – Escherichia coli.(1) They have the ability to thrive in 
a diverse range of conditions and are able to adapt to constant fluctuations in their 
environment, which impose cell stress.  
Cell stress is defined as ‘any change in the genome, proteome, metabolome or environment 
that imposes either reduced growth or survival potential.(2) The causes include changes in 
temperature, pH, osmolarity and ionic content.(3) This is representative across all bacteria 
and without the appropriate survival mechanisms, will undoubtedly result in cell death. For 
this reason, bacteria have evolved various different stress response mechanisms in an 
attempt to restore cellular homeostasis and prevent further stress challenges, which often 
respond via regulation of cellular processes often involving a feedback loop.  
Exposure to toxic compounds including reactive electrophiles is one significant example of 
cell stress. The presence of these electrophiles can result in changes to the redox status 
via the interaction with low molecular weight (LMW) thiols and they can alkylate and modify 
the functions of macromolecules such as DNA, RNA and proteins. A variety of mechanisms 
including export systems, repair systems and detoxification enzymes limit the damage to 
these nucleic acids and proteins.(2) 
Bacteria are commonly exposed to a wide range of electrophiles, some of which are toxic 
to the cell. This project focuses on the involvement of LMW thiol cofactors such as 
glutathione (GSH), cysteine (Cys) and bacillithiol (BSH) and their interaction with 
metabolites including methylglyoxal (MG).  
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1.1 LMW molecular weight thiols 
1.1.1. Overview 
The majority of bacteria require an oxidising environment to live, but in excess, this can be 
problematic to the cell. Therefore, it is important they maintain a redox-regulated 
intracellular environment. This relies on the interaction with specialised molecules in the cell 
that are capable of reducing these oxidative species through various biochemical 
processes.(4)  
These molecules are LMW thiol cofactors (figure 1.1), which play an important role in the 
maintenance and regulation of many cellular processes (scheme 1.1). For example, 
glutathione (GSH) is the most abundant LMW thiol found amongst eukaryotes and Gram-
negative bacteria. However, not all organisms produce GSH and they rely on other LMW 
thiol cofactors to undertake these cellular functions, which include the dominant LMW thiol 
cofactors, mycothiol(5) (MSH), trypanothione(6) (T(SH)2), glutathione amide(7) (GASH) and 
bacillithiol(8) (BSH).  In addition to their major LMW thiol cofactor, many organisms possess 
additional thiol cofactors which include, cysteine(9) (Cys), homocysteine(10) (HCy), coenzyme 
A(11) (CoA), ergothioneine(12) (ESH), and ovothiol(13) (OTH).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.1. The LMW thiols present amongst different organisms 
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Scheme 1.1. The general cellular functions of the dominant LMW thiols; 1) as a redox buffer; 2) in 
electrophilic detoxification of xenobiotics and reactive carbonyl electrophiles; 3) as an intracellular Cys 
reservoir; 4) in metal ion homeostasis; 5) in redox regulation of proteins. All these roles exist amongst 
the dominant LMW thiol cofactors being, GSH, MSH, T(SH)2 and BSH.  
1.1.2. Glutathione 
The majority of organisms including almost all eukaryotes and most Gram-negative bacteria 
utilise the dominant LMW thiol, glutathione (GSH).(14) GSH is a tripeptide containing glycine, 
cysteine and glutamate (figure 1.1). The biosynthetic pathway is a two-step enzyme 
catalysed process which involves an amide bond formation between Cys and glutamic acid 
catalysed by γ-glutamylcysteine ligase (GshA). This is followed by the addition of glycine 
onto the carboxylate of Cys, catalysed by the glutathione synthetase (GshB), forming GSH. 
The levels of GSH are regulated by feedback inhibition depending on the availability of 
Cys(15) where the intracellular concentrations of GSH are found to be present in the range 
of 3 – 7 mM in bacteria.(14) 
As previously mentioned, all aerobic organisms are subjected to oxidative stress which is 
problematic to the cell causing protein and DNA damage. In the presence of these oxidative 
species such as H2O2 and NO, two GSH molecules can be oxidised to form the GSH 
disulfide (GSSG) by the enzyme glutathione peroxidase which in turn is reduced back to 
GSH by glutathione reductase. This protects against oxidative stress and therefore plays a 
major role in maintaining a physiological redox status in cells.(16, 17)  GSH is also involved in 
other redox regulated processes including the post-translational modification for the redox 
regulation of proteins, by undergoing a process called glutathionylation, which is the 
formation of GS-S-protein mixed disulfides,(18) protecting cysteinyl residues on protein from 
oxidative stress. It also facilitates in metal ion homeostasis and is found to be involved in 
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the detoxification of toxic electrophiles (scheme 1.1). More recently, a derivative related to 
glutathione has been identified in prokaryotes, known as γ-L-glutamyl-L-cysteinylglycine 
amide (GASH) (figure 1.1). It exists in the cytoplasm of a purple anaerobe Allochromatium 
vinosum amongst the Chromatium species.(7) GASH is structurally very similar to GSH 
where an amide group replaces the carboxylate group of GSH. 
1.1.3. Amino acids 
Cysteine (figure 1.1) is an abundant LMW thiol present amongst all organisms and 
possesses a reactive thiol group.(19) The free thiol is present in all cells due to its importance 
as a main non-essential amino acid. It is present at low concentrations in the cell ranging 
from 0.03 - 0.2 mM depending on the stage of growth and organism.(20, 21) These low 
concentrations are a result of its involvement in protein synthesis.(22) Consequently, it is 
questionable to whether the levels of free Cys are sufficient to serve as a major thiol redox 
buffer. Similarly, homocysteine is another thiol-containing amino acid formed from the 
metabolism of methionine, which may play a role as a thiol redox buffer.(10)  
1.1.4. Other LMW thiols  
Most Gram-positive bacteria lack GSH, and Cys remains too low a concentration to serve 
as a major thiol redox buffer. (22) Therefore, the maintenance of a reduced environment relies 
on other LMW thiols. Mycothiol (MSH) is a major LMW thiol found amongst Actinobacteria 
including Mycobacterium, Corynebacterium and Streptomyces.(23, 24) It is composed of N-
acetylcysteine (CysNAc) and a pseudo-disaccharide comprised of a glucosamine and myo-
inositol (figure 1.1). It performs analogous functions to GSH (scheme 1.1),(14, 24) with the 
exception of one apparent difference being an additional pathway of xenobiotic 
detoxification. Herein, the mycothiol S-transferase (MST) first catalyses the conjugation of 
electrophile to mycothiol. The mycothiol-S-conjugate amidase (Mca) catalyses the 
mycothiol-S-conjugate producing mercapturic acid and glucosamine-myo-inositol (GlcN-
Ins) which is exported from the cell. (25) 
Trypanothione T(SH)2  is another dominant LMW thiol cofactor, formed from two molecules 
of GSH joined via a spermidine linker (figure 1.1), present amongst the parasitic protozoa 
in the Trypanosoma and Leishmania species.(6) It possesses comparable cellular functions 
to the other dominant LMW thiols including protection against oxidative stress, certain heavy 
metals, and xenobiotics.(26) 
Similar to Cys, there remain other LMW thiols which are found to only partially fulfil all the 
functions due to the involvement in other metabolic activity. One example includes 
coenzyme A (CoA) (figure 1.1), which is a LMW thiol cofactor present in all organisms and 
plays an essential role in metabolic processes such as lipid metabolism and the Krebs cycle. 
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In addition, the possession of the NAD(P)H-dependent CoA disulfide reductases (CoADR), 
have been isolated and characterised amongst, B. anthracis(27) and S. aureus(28), 
demonstrating CoAs involvement in redox regulation. However, a thiol pKa of 9.83(29) would 
mean that CoA exists entirely in its unreactive form at physiological pH due to no availability 
of the thiolate anion required in thiol-disulfide exchange reactions.(4) Therefore, due to this 
high thiol pKa and its involvement in other processes, it is questionable whether it serves as 
an efficient reducing buffer. 
Ergothioneine (ESH) is an aromatic 2-thiolhistidine (figure 1.1), which is only biosynthesised 
in Neurospora crassa(30) in fungi and in Mycobacterium smegmatis (31) in the Actinomycetes,. 
However, it exists in other organisms from dietary sources.(26, 31)  ESH exists in its reduced 
state at physiological conditions where it appears to serve as an effective antioxidant. 
However, no related enzymes have yet been discovered.  
The ovothiols A-C (OVO) compromise of an N-methyl-4-mercaptohistidine group (figure 
1.1), each with different degrees of N-methylation. They were first isolated from eggs and 
biological fluid of sea urchins and cephalopods amongst Echinoderms,(32)  and are widely 
distributed amongst other organisms including Dunaliella salina, a halotolerant blue-green 
algae(33) and Leishmania donovani, a T(SH)2 producing parasites.(32)  ESH and OVO both 
show similarities in molecular structure and biosynthetic pathways(34) where they play an 
important role in resistance to oxidative stress amongst the specific organisms.  
These LMW thiols are abundant amongst all organisms as they play a fundamental role in 
the redox processes within the cell. However, there remain many microorganisms with no 
identified LMW thiol. Only recently, the dominant LMW thiol, bacillithiol, emerged existing 
amongst the Firmicutes phylum in Gram-positive bacteria. 
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1.2. Bacillithiol  
1.2.1. Overview 
The dominant LMW thiol in low G+C Gram-positive bacteria, bacillithiol (BSH), an α-
anomeric glycoside of L-cysteinyl-D-glucosamine with L-malic acid, is functionally analogous 
to related LMW thiols including MSH and plays a dominant role as a redox buffer.(14, 35) It is 
widely distributed in Gram-positive bacteria amongst the Firmicutes.(22) These include 
species amongst the Bacillus genus including B. subtilis, B. anthracis, B. cereus, B. 
megatarium, B. pumilis and are present in small amounts in Geobacillus stereothermophilus 
amongst the Geobacilli. It also exists amongst the Staphylococcus genus including S. 
aureus and S. saphrophyticus in addition to  species in the Streptococcus and Arthrobacter 
genus (table 1.1), where is has been shown to exist in concentrations up to 5 mM in B. 
subtilis (table 1.2). Hence, it is found to be a widespread dominant thiol cofactor, emerging 
in many pathogenic strains of bacteria, highlighting its medical importance.(14)  
More recently, this thiol cofactor has been indicated in other phyla outside the Firmicutes 
and possibly in Gram-negative bacteria. The presence of the three biosynthetic genes has 
been bioinformatically proven amongst Chlorobium tepidum. HPLC analysis on Chlorobium 
tepdium indicated a derivative of BSH, N-methyl-bacillithiol, a newly discovered LMW thiol 
in green sulfur bacteria within the chlorobi phylum (Hiras, J unpublished 2017). 
Table 1.1. Intracellular concentrations of BSH µmol/g RDW(14) 
 
Strain of bacteria BSH concentration (µmol/g) RDW 
Deinococcus radiodurans 0.6 
Bacillus anthracis Sterne 0.2 
Bacillus cereus  0.3 
Bacillus megaterium  0.3 
Bacillus pumilis 0.7 
Bacillus subtilis 6051 0.3 
Bacillus subtilis CU1065 0.6 
Bacillus subtilis JH642 0.6 
Geobacillus stearothermophilus 0.07 
Staphylococcus aureus 0.7 
Staphylococcus saprophyticus 0.2 
Streptococcus agalactiae 0.2 
Arthrobacter aurescens 0.09 
Arthrobacter histodinolovorans  0.08 
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Table 1.2. Intracellular concentrations of thiols in B. subtilis, E. coli and human cells. 
Concentrations of LMW thiol cofactors (at late phase exponential in bacteria) 
Cofactor Organism Concentration Reference 
Cys B. subtilis  0.13 – 0.28 mM  (20)  
E. coli  0.02 mM (24) 
Human plasma 8 – 10  μM (36) 
BSH B. subtilis  0.5 - 5 mM  (20)  
GSH E. coli > 10 mM (37) 
Human plasma < 5 mM (36) 
 
1.2.2. Biosynthetic pathway of BSH 
BSH is biosynthesised in a three-step process (scheme 1.2). It is initiated by the enzyme 
glycosyltransferase (BshA)(38) which catalyses the glycosylation of L-malate and the 
substrate uridine diphosphate-N-acetylglucosamine (UDP-GlcNAc) to form the first 
intermediate N-acetylglucosamine malate (GlcNAc-Mal). An deacetylase (BshB)(39) then 
hydrolyses the acetyl group to form glucosamine malate (GlcN-Mal). The addition of Cys, 
catalysed by a cysteine ligase (BshC), produces the final product BSH (Cys-GlcN-Mal).(40, 
41) 
BshA is essential for the biosynthesis of BSH,(42) whereas, BshB is shown not to be 
necessary resulting in only a slight reduction of BSH in the mutant strain.(41) This is because 
it shares its deacetylase properties with BSH-S-conjugate amidase (Bca), which is also 
known to play a role in the drug detoxification of electrophiles.(22) There remains no evidence 
demonstrating the activity of BshC.(41)  However, in bshC mutant strains, there is no 
production of BSH.  
 
 
 
 
 
 
 
Scheme 1.2. Biosynthesis of bacillithiol. 
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1.2.3. Roles of BSH within the cell 
The primary role of BSH is as a redox buffer, analogous to GSH and MSH. It maintains a 
reduced intracellular environment via the reduction of oxidants to produce bacillithiol 
disulfide (BSSB) through thiol-disulfide exchange mechanisms (scheme 1.3). The thiolate 
attacks the sulfur atom of the disulfide in a nucleophilic substitution to form a transition state 
complex, before the thiol is liberated as a leaving group.(43) The thiolate representing the 
ionised form is dependent on the pKa of the thiol group which determines the rate of the 
reaction. These reactions are kept in a reduced form by NADPH-dependent flavoenzymes, 
known as the LMW thiol reductases, within the cell.  
In addition to playing a role as a dominant redox buffer, BSH is found to be involved in many 
other functions (scheme 1.4). It plays a critical role in the post-translational modification of 
proteins and prevents exposed Cys residues from irreversible damage during oxidative 
stress.(44) Reactive oxidative species interact with BSH forming the mixed disulfide with the 
Cys residues of proteins. The process of S-bacillithiolation, is the formation of BS-S-Protein 
mixed disulfide, which functions as the main redox-regulatory mechanism in response to 
oxidative stress.(45) The de-bacillithiolation is then the reverse process, which involves the 
breaking of the disulfide bond forming the BSH moiety and the protein, catalysed by the 
bacilliredoxins, YphP and YqiW.(45)  
BSH is also known to facilitate metal ion homeostasis. This is likely due to the close 
proximity of the amino and thiol group of the Cys moiety and carboxylate group of the malate 
moiety. It has been shown to chelate Zn2+ ions whilst maintaining the concentration of the 
free ion in the cytoplasm, acting as an effective buffer.(4) Therefore, it is anticipated that BSH 
functions as a reservoir of zinc and copper ions within the cell.(22) It is hypothesised to play 
a role in Fenton chemistry by reducing ferric ions and preventing oxidative stress caused 
by the reaction of metal ions and hydrogen peroxide generating hydroxide and hydroxyl 
radicals.(22)  
Another key role of BSH, analogous to the related thiols GSH and MSH, is its involvement 
in the detoxification of xenobiotics and electrophiles in both enzyme-catalysed and chemical 
reactions. 
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Scheme 1.3. Mechanism for thiol-disulfide exchange reactions. Reactive thiolate interacts with the 
disulfide in a nucleophilic substitution.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1.4. The cellular functions of BSH: 1) redox buffers; 2) redox regulation of proteins; 3) metal ion 
homeostasis; 4) speculated intracellular cysteine reservoir 5) detoxification of xenobiotic fosfomycin 6) 
detoxification of electrophiles. 
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1.3. Detoxification processes of xenobiotics and electrophiles 
The detoxification of electrophiles/xenobiotics occurs through interactions of thiols with the 
chemical species in either enzyme-catalysed reactions or a chemical reaction with highly 
reactive species.  
1.3.1 Enzyme-catalysed reactivity of thiols  
Thiols are known to react with many naturally occurring chemicals and xenobiotics. 
However, in some instances, the thiol is not a strong enough nucleophile to undergo these 
reactions. It therefore relies on the thiol-S-transferase enzymes, which lowers the thiol pKa 
and increases their reactivity.(41) Currently, there are over 15 different enzyme classes in the 
glutathione S-transferase (GST) superfamily where there are four known GSTs which have 
been well studied.(46, 47) More recently, the bacillithiol S-transferases (BST) have emerged 
and shown to be responsible for some forms of antibiotic resistance. FosB is a BST which 
is known to be involved in the detoxification of the antibiotic, fosfomycin. This enzyme 
catalyses the BSH-dependent ring opening of the epoxide moiety of fosfomycin, rendering 
it inactive (scheme 1.4).(4, 42, 48, 49) In addition, FosA is an equivalent S-transferase found in 
some GSH-utilising bacteria.(50) 
Another BST recently isolated in B. subtilis, has shown to be a member of the DinB 
superfamily. It contains the protein, YfiT, which catalyse xenobiotics in a BSH-dependent 
detoxification process.(51) YfiT has been shown to have S-transferase activity with 
monochlorobimane to form BSH-S-conjugates. Analogous to the MSH-dependent 
detoxification pathway present in mycobacteria,(52) an amidase, bacillithiol conjugate 
amidase (Bca), cleaves the amide bond to form GlcN-Mal and a Cys-S-conjugate. BshC 
catalyses the conversion of GlcN-Mal to reproduce BSH, whilst the Cys-S-conjugate is 
acetylated to form CysNAc-S-conjugates catalysed by cysteinyl S-conjugate 
acetyltransferase (CAT) where the conjugate is eventually exported from the cell (scheme 
1.5).(53) 
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Scheme 1.5. Bacillithiol S-conjugate amidase (Bca) catalysed detoxification pathway of electrophilic 
xenobiotics/metabolites to produce mercapturic acid.  
 
1.3.2. Chemical reactivity of thiols  
Over 20 reactive carbonyl-containing species which have potential to interact with thiols in 
the cell have been identified, including formaldehyde, glyoxal, methylglyoxal, 3-
deoxyglucosone and malondialdehyde.(54) In some instances, the carbonyl-containing 
species have proved to be good electrophiles, which interact with thiols non-enzymatically. 
For example, GSH has been shown to react with formaldehyde,(55, 56) a highly toxic 
metabolite produced as a by-product of methane and methanol metabolism. However, the 
most established reaction involves the highly reactive metabolite, methylglyoxal (MG), 
which was shown to react with GSH spontaneously, and follow through the thiol-dependent 
glyoxalase pathway.  
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1.4. Methylglyoxal 
1.4.1. Overview 
Methylglyoxal (MG) (scheme 1.6) is a toxic electrophile produced endogenously as a 
product of cellular metabolism, present in concentrations up to 1.5 mM in late exponential 
phase of E.coli.(57) It is composed of an aldehyde and ketone moiety, which co-exists as a 
monohydrate and dihydrate form in aqueous solution. As a strong electrophile found to be 
up to 20000-fold more reactive than glucose,(58) it is capable of non-enzymatically modifying 
macromolecules such as proteins, RNA and DNA causing a loss in biological activity 
(scheme 1.6).(59)  
1.4.2. Toxicity of methylglyoxal  
It was first identified that MG interferes with protein synthesis causing cell death in E. coli 
upon incubation of MG.(60) Studies have investigated the reactivity of amino acids with 
glyoxal derivatives, which were later confirmed to be involved in the formation of major 
advanced glycation end products (AGEs) in physiological systems.(61) Later on, it was 
shown that over 99% of methylglyoxal is reversibly bound to proteins.(62) In vitro experiments 
have shown that MG interacts with several protein amino acid side chains including 
arginine, lysine and cysteine.(63)  
MG has also shown to modify nucleic acids suggesting another significant cause for its toxic 
effects. It was first reported that reactive aldehydes such as MG possess anti-viral activity 
due the interactions it has with DNA, therefore causing cell damage.(64) MG has also shown 
to crosslink DNA polymerase and the substrate DNA.(65) Subsequently, the significance of 
MG interaction with nucleic acids was confirmed by a numerous amount of studies 
highlighting its potent reaction and toxicity that it may cause to the cell.(65-67) 
1.4.3. Formation of MG  
There are several pathways of enzymatic and non-enzyme catalysed formation of MG 
(scheme 1.6).  MG is formed from metabolic intermediates of carbohydrate, protein and lipid 
metabolism. The rate of formation of MG depends on the organism, tissue and cell 
metabolism and physiological conditions.(68) Acetoacetate is formed as a by-product of 
triglyceride metabolism. Acetone is then produced which is converted to acetol and then 
MG through a series of oxidation processes catalysed by the acetone and acetol 
monooxygenase, respectively. This pathway has only been known to exist in eukaryotes 
and has yet to be determined in bacteria.(69) Protein metabolism is another pathway of 
known MG formation. Herein, glycine and threonine can be degraded to form 
aminoacetone, which is then converted to MG, catalysed by amine oxidase.(70)  
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Glycolysis is found to be responsible for the majority of MG production. In glycolysis, 
glucose is metabolised in a 10-step pathway to form pyruvate. Fructose 1,6-bisphosphate 
produces one intermediate of each dihydroxyacetone phosphate (DHAP) and D-
glyceraldehyde 3-phosphate (GA3P). They are isomers of each other, where their 
interconversion is catalysed by triose phosphate isomerase (TIMs). DHAP is problematic to 
the cell if allowed to accumulate as it contains a phosphate group which can therefore cause 
phosphate starvation within the cell. Therefore, the cell deals with high DHAP levels through 
the formation of MG, which occurs spontaneously(71) or via the catalysis of MG synthase 
(MgsA).(72) When MG is formed from DHAP, an inorganic phosphate is given off which is 
used to replenish the concentration of needed inorganic phosphate.(73-75) However, this 
leads to the accumulation of MG.  
 
Scheme 1.6. The metabolism of methylglyoxal in eukaryotes. The enzymes are the following:- 1) amine 
oxidase 2) triose phosphate isomerase 3) methylglyoxal synthase 4) acetone monooxygenase 5) acetol 
monooxygenase 6) aldehyde dehydrogenase 7) 2-oxoaldehyde dehydrogenase 8) aldose reductase 9) 
methylglyoxal reductase 10) glyoxalase I/II. 
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1.4.4. Enzymes involved in the formation of MG  
Triosephosphate isomerase (TIMs) catalyses the interconversion between GA3P and 
DHAP (scheme 1.7). This enzyme is a key component of glycolysis and is present in large 
concentrations to accommodate for the high levels of glucose undergoing metabolism. An 
enediolate intermediate is formed as an intermediate by TIMs formed from either DHAP or 
GA3P. With GA3P as a substrate, the Km = 0.25 mM, kcat = 6.2 x 103 s-1 and the catalytic 
efficiency is 2.5 x 104 mM-1 s-1. With DHAP as a substrate, the Km = 1.2 mM, kcat = 1.1 x 103 
s-1 and the catalytic efficiency is 903 mM-1 s-1.(76) Therefore, there is a less efficient turnover 
for DHAP as a substrate relative to GA3P.(77)  
MG synthase (MgsA) predominantly exists amongst bacteria but has recently been shown 
to exist in goat liver.(68) The enzyme is found to catalyse the conversion of DHAP with a Km 
= 0.47 - 0.56 mM, kcat = 325 s-1 and a catalytic efficiency of 613.2 mM-1 s-1.(78, 79) Only the 
crystal structure of the bacterial enzyme has been determined.(80, 81) The specific reactivity 
of the enzyme is shown to be 25-fold greater than mutants strains, possessing an activity 
of 0.142 – 0.190 μM/min/mg protein amongst E. coli.(72) The absence of any known MgsA 
does not mean that MG does not exist amongst eukaryotes, as both DHAP and GA3P are 
found to be unstable at physiological cell conditions to form MG.  The rate constant for 
DHAP and GA3P breakdown to MG in Kreb-Ringer phosphate buffer at 37 °C is 1.94 s-1 
and 1.54 s-1, respectively.(71, 82) Therefore, this is indicative that this degradation occurs 
amongst all eukaryotes.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 1.7. The formation of MG via carbohydrate metabolism. GA3P and DHAP isomerises to form an 
enediolate intermediate.  
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1.5. Detoxification pathways of methylglyoxal  
The toxic effects of MG makes it essential that the cell utilises the appropriate survival 
mechanisms. Currently, several MG detoxification pathways have been identified. Amongst 
bacteria, these include the thiol-dependent glyoxalase I-II pathway, the thiol-independent 
glyoxalase III pathway, and the MG reductase and dehydrogenase enzymes.  
1.5.1. Thiol-independent detoxification pathways 
The thiol-independent pathways of MG detoxification consist of several enzyme-catalysed 
reactions forming 1,2-propanediol, D-lactate and pyruvate, amongst bacteria. The two 
alpha-keto aldehyde dehydrogenase enzymes were the first thiol-independent MG 
detoxification enzymes to be discovered. They involve NAD and NADP-dependent oxidation 
of MG to pyruvic acid (scheme 1.6). (83, 84) Additionally, the aldose reductases, have shown 
to catalyse MG to form D-lactaldehyde and acetol, which then forms propanediol (scheme 
1.6).(85-88) The YafB, YqhE, YeaE and YghZ proteins have been identified in E.coli.(86) In 
addition, B. subtilis has been shown to possess YhdN, the only known protein to be an 
aldose reductase amongst Gram-positive bacteria.(74)  However, the most significant 
pathway of detoxification is thiol-dependent, which amongst eukaryotes is known as the 
GSH-dependent glyoxalase detoxification.  
1.5.2. Thiol-dependent detoxification pathways 
1.5.2.1 The glyoxalase pathway  
The major MG detoxification pathway uses LMW thiol cofactors, which interact with MG and 
follow through a series of enzyme catalysed reactions known as the glyoxalase pathway.(89) 
Herein, MG non-enzymatically reacts with GSH to form a hemithioacetal (HTA) which in 
turn serves as a substrate for the glyoxalase I (GlxI)(90) enzyme (S-D-lactoyl-glutathione 
methylglyoxal-lyase), which isomerises the HTA to produce S-D-lactoyl-GSH. The 
glyoxalase II (GlxII)(91) enzyme, (S-2-hydroxyacylglutathione hydrolase), catalyses the 
hydrolysis of S-D-lactoyl-GSH to produce D-lactate while recycling the GSH (scheme 1.8). 
(92, 93)  
 
 
Scheme 1.8. The thiol dependent glyoxalase pathway.  
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1.5.2.2 The glyoxalase enzymes 
GlxI is a member of the metalloglutathione transferase superfamily.(94) The enzyme has 
been characterised in humans, plants, yeast and a number of strains of bacteria including 
E. coli, Yersinia pestis, Pseudomonas aeruginosa and Neisseria meningitidis.(95-97) Recent 
data have emerged showing that there are different substrates for glyoxalase I including the 
GSH adducts with hydroxypyruvaldehyde, glyoxal and phenylglyoxal.(98) GlxII is shown to 
possess no similarities to GlxI. There is no characterised glxII amongst the prokaryotes. It 
is a member of a superfamily of hydrolases which includes the metallo-β-lactamases(99) and 
has a broad specificity for thioesters such as S-D-lactoyl-GSH.  
Glyoxalase III (GlxIII) is an enzyme capable of catalysing the conversion of MG directly to 
D-lactate, with no need for GSH.(100) There is no current data of the class of enzymes of 
GlxIII. Research has emerged showing there are three enzymes which have been predicted 
to be homologues of glyoxalase III that convert MG to D-lactate, these being YdeA, YraA, 
YfkM, amongst B. subtilis.(74) However, this enzyme is found to have a minor contribution 
towards the overall degree of detoxification of MG.(101) The catalytic efficiency of GlxIII is 
found to be approximately 160-fold less efficient than GlxII and approximately 15000-fold 
less efficient than the GlxI (table 1.3). This large difference in catalytic efficiency confirms 
the overall significance of GlxI/II detoxification pathway over the thiol-independent 
glyoxalase III enzymes.  
 Table 1.3.  The enzyme kinetics of the three glyoxalase enzymes of MG-SG substrate in E. coli strains 
 
 
 
 
 
 Substrate Km (mM) kcat (s-1) kcat / Km  
(mM-1 s-1) 
catalytic 
efficiency 
Organism 
GlxI MG-SG 0.027(102) 338-1120(102) 12,518-41,481 E. coli 
GlxII S-D-lactoyl-GSH 0.184(103) 53(103) 288 E. coli 
GlxIII MG 1.430(57) 2.615(57) 1.8 E. coli 
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1.5.2.3. KefB and KefC efflux system  
The S-D-lactoyl-GSH intermediate also activates the KefB + KefC K+ efflux system causing 
an efflux of potassium ions and H+ influx, which protects against electrophiles by the 
lowering of the cellular pH.(104) A lower cellular pH results in a more protonated state and 
therefore less reactive form of the amino groups on DNA and proteins, and consequently, 
there is a reduced reactivity with electrophilic species in the cell such as MG (scheme 
1.9).(74, 101)   
 
 
 
 
 
 
 
Scheme 1.9. S-D-lactoyl-RSH causes cytoplasmic acidification through the influx of H+. 
 
1.5.3. Does the BSH-dependent glyoxalase system occur in Gram-positive bacteria? 
The pathway for GSH-dependent glyoxalase detoxification has been well established. It is 
found to be responsible for 70% of detoxification of MG in E.coli strains.(105) Considering the 
importance of this pathway amongst eukaryotes, the role of BSH amongst Gram-positive 
bacteria in the modification of MG has not been sufficiently investigated.  The past research 
has reported that B. subtilis mutants lacking BSH are sensitive to MG, suggesting that, 
similar to GSH, BSH plays a role in the detoxification of MG.(53)  It has also been reported 
that BSH confers protection against MG by converting MG to D-lactate where MG is 
responsible for rapidly depleting BSH in cells, providing some evidence that BSH follows 
through the glyoxalase pathway.(52) However, more research will be required to gain a full 
understanding of the involvement of BSH in the detoxification pathway. 
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1.6. Objectives of the research  
The main objective of this research is to study the initial interaction of BSH with MG forming 
the HTA (scheme 1.10 ii/iii), which then proceeds through the glyoxalase pathway (scheme 
1.10 vi). In vitro kinetics will focus on the initial step of chemical reactivity, i.e. the reaction 
between thiol and MG. This will include the determination of the relative rates of reactivity 
of MG with the different LMW thiols including BSH, Cys, GSH and CysNAc. In addition, the 
forwards and reverse rate constants of this reaction will produce a general idea of the most 
reactive thiols involved in this detoxification process.    
For the in vivo studies, B. subtilis is used as the model organism. It is a soil dwelling Gram-
positive bacteria, known to possess BSH as the dominant LMW thiol cofactor.(20) B. subtilis 
cells will be stressed with excess MG to determine the effects on the growth of the bacteria, 
as well as the intracellular thiol concentrations. In addition, the extracellular MG 
consumption will be investigated, to confirm the uptake and subsequent detoxification in the 
cell. In addition, there is relevance in determining the effects of MG on different levels of 
carbohydrate stress as MG is a by-product of glycolysis. Therefore the in vivo studies will, 
in general, potentially confirm the in vitro observations whilst also providing more evidence 
of the BSH involvement in the glyoxalase pathway.  
Further studies will be carried out to confirm the formation of HTA. This will involve 
determination of the mass of HTA using mass spectrometry, in addition to NMR analysis of 
in vitro samples of HTA. This may potentially identify alternative products as a result of thiol 
reacting with MG. The evidence of these products will then be investigated using whole cell 
NMR analysis, providing direct in vivo evidence under physiological conditions that these 
HTAs are formed from the reaction between MG and BSH.  
In summary, as BSH remains a newly discovered cofactor, there is much importance in 
unravelling its metabolic roles in the cell. Herein, this research focuses on investigating the 
nucleophilicity of BSH and its interaction with various electrophiles such as MG to form a 
possible HTA or a thiazolidine derivative. This will give us a greater understanding of the 
cellular functions of BSH amongst Gram-positive bacteria. Furthermore, it introduces the 
possibility of further interactions of LMW thiols with carbonyl-containing metabolites, which 
have the potential to exist amongst other organisms including eukaryotes and therefore of 
potential relevance in health-related conditions. 
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Scheme 1.10. Main objectives of this research project. i) Explore the relative reactivity of the four LMW 
thiol cofactors ii) Determination of rate constants for forwards and reverse reaction of Cys-MG HTA iii) 
Determination of rate constants for forwards and reverse reaction of BS-MG HTA iv) Determination of 
alternative detoxification pathways including the possible formation of a thiazolidine derivative v) 
Intracellular concentrations of MG vi) Exploration of the full involvement of thiol in the BSH-dependent 
glyoxalase pathway including thiol analysis and extracellular determination of MG concentration. vii) 
Analysis of the carbohydrate effects on growth, thiol levels and MG levels. viii) Whole cell NMR proving 
existence of BS-MG HTA. 
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2. Methylglyoxal and its interaction with low 
molecular weight thiols 
 
 
2.1. Overview 
The GSH-dependent glyoxalase detoxification pathway has been well established as the 
predominant detoxification pathway amongst GSH-utilising organisms.(89, 93, 98, 106) However, 
research remains limited into investigating the reactivity of other LMW thiols with MG. 
Although there is evidence that BSH reacts with MG and follows through the BSH-
dependent glyoxalase pathway demonstrated in B. subtilis(74)  (scheme 2.1), the focus of 
this chapter will involve investigating the roles of BSH as a chemical scavenger, primarily 
looking at the initial chemical reaction of BSH with MG in the formation of HTA (scheme 
2.1A).  Herein, the relative rates of reactivity, the rate constants, in vitro and in vivo studies 
of LMW thiols reacting with MG were determined, to produce an overall idea into the extent 
of involvement of each thiol in the detoxification process.  
 
 
 
 
 
 
 
 
Scheme 2.1. The three reactions of the glyoxalase pathway. 
 
 
 
(A)  
 
 
 
(B) 
 
 
 
(C) 
 
 
 
 
 
D 
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2.2. In vitro chemical reactivity between LMW thiol cofactor and MG 
2.2.1. Reactivity of LMW thiol cofactors   
In the initial step, the thiol non-enzymatically reacts with MG to form an HTA, which follows 
second order reaction kinetics (scheme 2.1A). The thiol is a reactive nucleophile, which 
interacts with the aldehyde on the MG forming the HTA. It is also possible for the ketone on 
the MG to react, however this is a less likely reaction due to the steric effects and electron 
donating effects of the additional methyl group. Both Cys and BSH possess a zwitterionic 
nature as they also contain an amino group, which can potentially undergo reactions with 
electrophiles such as MG. However, previous research has shown that the thiol group is 
more likely to interact with the carbonyl group rather than the amino group, due to the thiol 
group being more nucleophilic.(107-109) In addition, it has previously been established  that 
the presence of  thiol has prevented the amino group to form hemiaminal.(110) In addition, 
the electrons in the outermost shell are more available to undergo a nucleophilic attack in 
sulfur relative to nitrogen due to the larger atom and lower electronegativity of the element.  
For these reasons, the research focuses predominantly on the reactivity of the thiol groups.  
2.2.2. Influence of pKa on the reactivity of LMW thiol cofactors   
When investigating the reactivity of LMW thiols, an important aspect to consider is the pKa 
of the thiol group. This reflects the proportion of thiol in its deprotonated form, known as the 
thiolate anion, which is the more reactive form representing a strong nucleophile. The lower 
the pKa, the more deprotonated the thiol group and the higher the concentration of thiolate 
present at a specific pH. The zwitterionic nature of Cys and BSH have four ionisable forms, 
which represent the microscopic pKa of the thiol cofactors (scheme 2.2, table 2.1).(20)The 
thiol pKa of BSH is 7.97, which is found to be lower than Cys which has a thiol pKa of 8.38. 
It is speculated that the protected cysteinyl carboxylate on the BSH with the uncharged 
amide group increases acidity of the thiol group by inductive effects.(20) In addition, the thiol 
pKa of BSH is found to be significantly more acidic than GSH, which has a thiol pKa of 8.93. 
This is possibly explained by the absence of a positively charged amino group on the Cys 
moiety which is responsible for stabilising the thiolate anion. As a result, the BSH is present 
in highest thiolate concentrations relative to Cys and GSH. At physiological pH in B. subtilis, 
pH 7.7, the percentage of thiolate for GSH, Cys and BSH are 6%, 15% and 22%, 
respectively (figure 2.1).(20) Therefore the thiol pKa is likely to have a significant effect on the 
rate of reactivity of LMW thiols with potential electrophilic groups. 
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Table 2.1. The microscopic pKa of the LMW thiol cofactors, Cys, BSH and GSH.  
 
A)                                                                                 B) 
Figure 2.1. A) The pH-dependent proportions of total thiolate forms of Cys-, BS- and GS-. B) The pH 
dependent proportions of thiolate forms of Cys-, BS- and GS- at pH 5.6 and pH 7.7.[1] 
Microscopic pKa  Cys(20) BSH(20) GSH(111) 
pKs(a) 8.38 7.97 8.93 
pKn(a) 8.77 7.63 9.13 
pKns(a)  9.94 9.55 9.08 
pKsn(a) 10.40 9.21 9.28 
(a) The thiol pKa abbreviations are indicated in scheme 2.2. 
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2.2.3. Purification of MG 
The majority of studies in this chapter use MG. Whilst MG is commercially available as a 
40% aqueous solution, these solutions are contaminated with other molecules. Therefore 
to ensure that these studies are attributed definitely to MG, pure stocks were prepared 
from pyruvaldehyde dimethyl acetal (scheme 2.3).(112)  Dowex-X8 resin (H+-form, 2.5 g) 
was washed with water and treated with 1 M HCl. The resin was filtered and washed with 
water until reaching a neutral pH. A mixture of pyruvaldehyde dimethyl acetal, Dowex-X8 
(H+-form, 2.4 g) in MQ water was heated at 95 °C under a nitrogen atmosphere for 90 min 
and left overnight at room temperature. Water was added and the mixture was 
concentrated to a volume of ~120 mL under vacuum, and this was repeated five times. 
Finally, the Dowex resin was removed by filtration. The concentration of MG was 
determined by quantitative 1H NMR (425 mM, >98% purity).  
 
  
Scheme 2.3. Purification of MG. 
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2.2.4. Relative reactivity of Cys and BSH with MG 
In vitro experiments were carried out to determine the rate of thiol consumption of BSH and 
Cys when reacted with MG. Herein, thiol (100 μM – 2000 μM) was reacted with excess MG 
(1500 μM) in a sodium phosphate buffer pH 5.6. Stopped assays were carried out where 
aliquots equating to 50 μM at t = 0, were removed at 10-second time points and quenched 
with Ellman’s assay, to quantify the residual RSH (scheme 2.4).  
The reaction between MG and thiol follows second order reaction kinetics. However, the 
reaction was carried out under pseudo-first order reaction conditions by using an excess of 
MG (1500 μM) relative to the thiolate concentration (0.15 – 4.6 μM). As a result, there is 
negligible consumption of MG over the course of the reaction, to produce a zero order 
reaction with respect to MG and a first order reaction with respect to thiolate. These 
conditions were used to produce a linear initial rate of thiol consumption and therefore allow 
an accurate comparison of both Cys and BSH reactivity with MG. As previously mentioned, 
physiological pH in the model organism, B. subtilis, is pH 7.7. However, the reactions could 
not be monitored at this pH because of the speed of the reaction, with a full consumption of 
Cys taking place within seconds. This was rectified by carrying out the reactions at pH 5.6, 
where only 0.46% of BSH and 0.15% of Cys is deprotonated. Therefore, there was a lower 
thiolate concentration resulting in a decreased rate of reactivity allowing the initial rate of 
thiol consumption to be determined.  
 
Scheme 2.4. Thiol quantification showing a thiol-disulfide exchange reaction between DTNB and 
reactive thiolate. 
 
 
46 
 
Figure 2.2. Reactivity of Cys/BSH (and thiolate anions) with MG (1500 μM) at; A) equivalent thiol 
concentrations at 70 mM; B) thiol concentration of Cys and BSH concentration at 218 μM and 70 μM, 
respectively, which correspond to the same thiolate concentration (0.29 μM) in sodium phosphate 
buffer, pH 5.6, 20 °C. 
When comparing the relative rates of reactivity of BSH and Cys at pH 5.6, BSH is 5-fold 
more reactive than Cys at the same initial thiol concentration (figure 2.2A). This is 
represented by an initial rate of reaction of 2.9 μM/s for BSH as opposed to 0.56 μM/s for 
Cys. However, the rates are comparable when the same initial thiolate concentration of BSH 
and Cys are used (figure 2.2B). Cys consumption represents linearity for the first 60 
seconds. However, the rate of consumption of BSH slows down after 10 seconds 
suggesting that it is attaining equilibrium. 
The BSH and Cys thiolate represent equal reactivity; therefore, the predominant thiol 
species is based on the thiol pKa and intracellular concentrations of the individual thiol.  BSH 
has a lower thiol pKa, and thus there is a higher portion of BS- thiolate over the Cys thiolate 
at a specified pH (figure 2.1B). In addition, there is a higher intracellular concentration of 
BSH at approximately 3 mM at late-exponential phase of B. subtilis growth.(20) As a result, 
it can be concluded, that there is strong in vitro evidence to show that BSH reacts 
preferentially over Cys, identifying it as a main cofactor in MG detoxification. 
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2.2.5. The reactivity of other LMW thiols, GSH and CysNAc, with MG 
The reactivity of other LMW thiols were then investigated. In view of GSH being the 
dominant thiol in eukaryotes, there is significant research that has investigated the reactivity 
of this thiol cofactor with MG and other carbonyl-containing molecules, dating back to 
1934.(98, 106, 113, 114) Although there is extensive research, the assays of GSH and MG 
reactivity were carried out in a similar approach to Cys and BSH assays to allow an effective 
comparison. The thiol pKa’s of GSH and CysNAc, are 8.93 and 9.52, respectively.(115) There 
is approximately 10-fold less thiolate of GSH and 38-fold less thiolate of CysNAc at pH 5.6 
relative to BSH. So, CysNAc (4200 μM) and GSH (2100 μM) were individually reacted with 
MG (5 mM) at pH 5.6, representing a comparable thiolate concentration to the Cys/BSH 
assays. As a result, both GSH and N-acetylcysteine (CysNAc) showed no reactivity with 
MG over a 3-hour period. The reaction was then investigated at a higher pH 7.7 with thiolate 
concentrations of approximately 200 times more concentrated relative to the Cys- and BS- 
thiolate concentrations at pH 5.6. The reactivity was analysed over a 20-minute period. GSH 
reacted with MG, producing a rate of reactivity of 9.53 nM/s (figure 2.3), showing a 
substantially decreased rate of reactivity when compared with BSH and MG. No reactivity 
of CysNAc was observed which is shown to differ in other research which demonstrates 
reactivity with MG to be approximately 3-4 times less reactive than Cys, regulated at 37 °C, 
pH 7.4, over a 6 hour time-period.(110)   
Whilst the thiol pKa has a large effect on the rate of reactivity of the thiol, the equally reactive 
BS- and Cys- at comparable thiolate concentration are shown to possess significantly faster 
rates of reactivity relative to GSH and CysNAc. Therefore, this suggests other aspects need 
to be taken into consideration. These include the chemical properties and steric effects of 
the individual thiol. Whilst BSH possesses the highest molecular weight, the thiol group on 
GSH is the most sterically hindered as it consists of an N-terminal glutamate on the Cys 
moiety. In addition, previous research has reported the availability of the amino group has 
been shown to affect the reactivity of a thiol group.(110)  
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Figure 2.3. The rate of reactivity of GSH (2100 μM thiol, 61 μM thiolate) and CysNAc (4200 μM thiol, 61 
μM thiolate) with MG (5000 μM) in HEPES pH 7.7, 20 °C, over a 20-minute time-period. 
 
2.2.6. Long-term reactivity of thiol with MG 
This research has predominantly investigated the initial rate of reactivity of thiols with MG 
determining the immediate kinetics. However, it remains unknown as to whether the thiol 
remains the predominant reactive group or the amino group may potentially be involved. 
This was investigated by monitoring the course of this reaction over a longer period.  
The reactivity was monitored in a RSH:MG ratio of 1:1 and 1:5, at pH 7.4, at 20 °C, over a 
4-hour period. For the 1:1 ratio, the majority of thiol had reacted within 2 minutes, with 80% 
reactivity of BSH and 60% reactivity of Cys. As the reaction proceeds, after reaching 80% 
reactivity of thiol groups for both BSH and Cys, the percentage of free thiol groups gradually 
decreases over the 4 hours (figure 2.4A). A similar reaction was observed in excess MG 
(figure 2.4B). As previously discussed, both Cys and BSH contain the nucleophilic thiol and 
amino group. It is known that there is an initial immediate reaction with the thiol group after 
the first 2 minutes representing the thiol group being involved in the fastest reaction process. 
Then the percentage of reacted thiol groups decreases which could represent a dissociation 
of the HTA and the formation of the hemiaminal from the amino group reacting with MG 
(scheme 2.5).(110) 
 
 
 
 
Scheme 2.5. Reaction of thiol and MG forming HTA and possibly hemiaminal 
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The reaction course curves differ significantly in other related LMW thiols including CysNAc 
and GSH.(110)  Under the same conditions, it is reported that only 14% of thiol groups for 
GSH and 7% of thiol groups for CysNAc react within the first minute which gradually 
increases over the next 2 hours(110). Therefore, suggesting that the reactivity of thiol groups 
of all LMW thiols with MG, decreased in order BSH > Cys > GSH > CysNAc.(110) This 
complies with the original kinetics investigating the relative rate of reactivity’s of the different 
thiols (chapter 2.2.4, 2.2.5).  
Figure 2.4. The time course of reaction of thiol groups with MG in reactant ratios of A) 1:1 2 mM RSH: 2 
mM MG and B) 1:5 2 mM RSH: 10 mM MG at incubation in sodium phosphate buffer pH 7.4 at 20 °C. 
 
2.2.7. Potential thiazolidine formation 
Following HTA formation, in the case of both Cys-MG and BS-MG HTA, the presence of a 
thiol and amino group in close proximity, has the possibility of forming a thiazolidine 
derivative (scheme 2.6).(110, 116-118) It has shown to be more stable than the HTA and it is 
therefore plausible that there are higher concentrations of thiazolidine present in the cell,(119) 
representing another possible mechanism of detoxification for MG. 
 
 
 
 
Scheme 2.6. Chemical scheme of thiol reactivity with MG to form HTA and then thiazolidine.  
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2.3. pH-dependent (pH 5.6) and pH-independent rate constants 
2.3.1. Overview 
Experimental analysis was required to determine the rate orders (chapter 6.5.4). This was 
carried out by investigating the fold-change of the rate of reaction when the concentration 
of a single species is changed. As a result, under excess MG concentration, a pseudo-first 
order reaction exists (Eq. 2.2). In addition, the dissociation of HTA also represents a first 
order reaction (Eq 2.3).  
Rate of forwards reaction = k2 [C=O][RSH] 
Rate of forwards reaction = k1 [RSH] (under pseudo-first order conditions) 
Rate of reverse reaction = k-1 [HTA] 
 
 
 
Scheme 2.7. Carbonyl-containing metabolite reacting with thiol to form HTA, representing k2 and k-1 
 
2.3.2. Forwards rate constant (k1) of thiol and MG reactivity 
Under physiological conditions, many factors can alter the rate of reactivity of thiols reacting 
with MG. Other than the complexity of the cells with the many on-going cellular processes, 
the pH greatly affects the rate of reactivity of thiol with MG. Therefore, the data showing the 
relative rates of reactivity (chapter 2.2.4, 2.2.5) are limited because they represent only a 
specific concentration at specified pH of thiol reactivity. This was overcome by determining 
the pH-independent rate constants, which investigates the rate of reaction taking into 
account all the different thiolate concentrations.  
The rate constants were determined for the reactivity of MG with Cys and BSH. The initial 
rate of reaction was first determined by investigating the consumption of thiol at different 
initial concentrations with excess MG (1500 μM). As a result, > 5 varied gradients 
representing a rate of reaction at different initial concentrations were produced (figure 
2.5A/B). A plot of the initial rate of reaction against the initial thiol concentration produces a 
gradient which represents the rate constant (k1) at pH 5.6. In addition, the plot which 
represents the thiolate concentration shows a gradient which represents the pH-
independent rate constant (k1) (figure 2.5D). The second order rate constant was then 
(Eq. 2.1) 
(Eq. 2.2) 
(Eq. 2.3) 
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determined by dividing the pseudo-first order rate constant by the MG concentration (table 
2.2). 
The pseudo-first order rate constants represented by the formation of HTA between MG 
with Cys and BSH were found to increase linearly up to 0.5 mM and 0.1 mM, respectively 
(figure 2.5C). However, above these concentrations, the rates of reaction levels off and 
becomes independent of MG concentration. This is shown by a hyperbolic curve 
representing a decreased rate of reaction at higher concentrations of Cys/BSH. The reason 
for this is possibly due to a higher concentration of MG in its hydrate form which is not 
detected in the Brady’s reagent quantification of MG due to the different reaction conditions. 
As a result, there are lower concentrations of the keto- form of MG. 
The reactivity of MG with BSH is found to have approximately 3-fold increase in rate of 
reactivity in comparison to MG with Cys (figure 2.5C), which reflects the relative rate of 
reactivity in preliminary investigation (figure 2.2A). However, the pH-independent rate 
constants which investigates the reactive species being the thiolate, were found to show 
approximately the same level of reactivity of each thiol with MG (figure 2.5D).  
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Figure 2.5. A)  The consumption of Cys (100 μM – 2000 μM) with MG (1500 μM) in HEPES buffer (50mM), 
pH 5.6, 20 °C, representing pseudo first order reaction kinetics with each gradient representing the 
reaction rate. B) The consumption of BSH (100 μM – 1000 μM) with MG (1500 μM) in HEPES buffer 
(50mM), pH 5.6, 20 °C, representing pseudo first order reaction kinetics. C) The two rate constants of 
MG reactivity with Cys/BSH, at pH 5.6 D) The two pH independent rate constants of MG reactivity with 
Cys/BSH. Data was carried out in duplicate where error bars show ± SEM. 
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2.3.3. Reverse rate constant (k-1) of HTA dissociation 
The dissociation rate of HTA forming thiol and MG was determined. Thiol (5 mM) and MG 
(10 mM) was initially reacted in HEPES pH 7.7 until there was a full consumption of thiol, 
confirmed by Ellman’s reagent, implying that the HTA has formed (scheme 2.4).  Several 
dilutions of the newly formed HTA (125 - 750 μM) were then individually quenched with 
Ellman’s reagent, pH 7.7. The Ellmans’ reagent labels the residual thiol resulting in a shift 
in equilibrium allowing the dissociation of HTA to be determined (scheme 2.8). An increase 
in absorbance represents thiol being liberated as the HTA dissociates back to form thiol and 
MG (figure 2.6).  
The gradient produced represents the dissociation rate constant (k-1), which is observed in 
a linear range (figure 2.7A/B). It shows the dissociation of HTA to form BSH and MG to be 
faster than the dissociation of HTA from Cys and MG, by 5-fold (figure 2.7C). In each 
instance, the reverse rate is significantly slower than the forwards rate (table 2.2). 
Therefore, suggesting that the formation of HTA in the reaction of thiol and MG is favoured. 
 
Scheme 2.8. DTNB reacting with residual thiolate therefore altering the equilibrium allowing 
determination of the off-rate of reaction. 
Figure 2.6. UV-vis spectrum showing the off rate of reactivity represented by the formation of thiol from 
HTA, which then further reacts to form the UV-active TNB2-. Thiol (5 mM) and MG (10 mM) was reacted 
in HEPES pH 7.7 until equilibrium was reached. A range of different HTA concentrations A) 125 μM, B) 
250 μM, C) 375 μM, D) 500 μM were prepared in Ellman’s reagent, pH 7.7. 
A 
B 
C 
D 
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Figure 2.7 A)  The dissociation of HTA (125 μM – 750 μM) using DTNB (2 mM) in HEPES buffer (50 mM) 
pH 7.7, 20 °C, over 500 seconds after carrying out an initial reaction of Cys (5 mM) with MG (10 mM) in 
HEPES buffer (50mM), pH 7.7, 20 °C, with each gradient representing the reaction rate. B) The 
dissociation of HTA (125 μM – 500 μM) using DTNB (2 mM) in HEPES buffer (50 mM) pH 7.7, 20 °C, over 
250 seconds after carrying out an initial reaction of BSH (5 mM) with MG (10 mM) in HEPES buffer 
(50mM), pH 7.7, 20 °C, with each gradient representing the reaction rate.  C) The two dissociation rate 
constants of HTA to form DHAP and Cys/BSH, at pH 7.7. Data was carried out in duplicate where error 
bars show ± SEM. 
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2.4. Thermodynamics – equilibrium constant (Keq).  
The pseudo-first order rate constant (k1) was determined at pH 5.6, whereas the reverse 
rate constant (k-1) was determined at pH 7.7. For the determination of the equilibrium 
constant, it is necessary the forwards and reverse reaction are at the same pH. Therefore, 
the predicted forward rate constants (k1) were calculated at pH 7.7 to give a value of 1.13 
s-1 and 2.08 s-1 for the reactivity of MG with Cys and BSH, respectively. Furthermore, the 
second order rate constants were then calculated to give a value of 753.5 M-1s-1 and 897.4 
M-1s-1 for the reactivity of MG with Cys and BSH, respectively (table 2.2). The equilibrium 
constants were then determined (table 2.4) by incorporating the second order rate constant 
over the reverse rate constant (k2/k-1). As a result a large value (>105) is found suggesting 
that the forwards rate of reaction is favoured.  
Table 2.2. Pseudo-first order rate constant (k1), second order rate constant (k2) and reverse rate (k-1) 
constants for HTA formation from Cys and BSH reactivity with MG  
 Rate constant pH 
5.6 
(±SEM) 
Rate constant  pH 
7.7a 
(±SEM) 
pH-independent rate 
constant 
(±SEM) 
Pseudo-first order rate constant (k1) with respect to thiol 
Cys-MG 1.39 x 10-2 s-1 
(±5 x 10-5) 
1.13 s-1 
(±4.1 x 10-3) 
9.46 s-1 
(±2.2 x 10-2) 
BS-MG 4.36 x 10-2 s-1 
(±1.25 x 10-3) 
2.08 s-1 
(±6.0 x 10-2) 
7.55 s-1  
(±0.73) 
Second order rate constant (k2) 
Cys-MG 9.3 M-1s-1 
(±3.3 x 10-2) 
753.3 M-1s-1 
(±2.7) 
6306.6 M-1s-1 
(±14.7) 
BS-MG 29.1 M-1s-1 
(±0.83) 
897.4 M-1s-1 
(±40) 
5033 M-1s-1 
(±486.7) 
Reverse rate constant (k-1) 
Cys-MG - 1.242 x 10-5 s-1 
(±1.5 x 10-7) 
- 
BS-MG - 6.262 x 10-5 s-1 
(±5 x 10-7) 
- 
aRate constant could not be determined at this pH because of the speed of the reaction and 
therefore the rate constant has been calculated based on the thiolate concentrations at pH 7.7 
relative to pH 5.6. 
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Table 2.3. The half-life for the dissociation of HTA to form free thiol and MG. 
  
 
 
Table 2.4 Determination of equilibrium constants from thiol and MG. 
Equilibrium constant for Cys and MG                         Equilibrium constant for BSH and MG 
 k2 [C=O][Cys] = k-1 [HTA]                                      k2 [C=O][BSH] = k-1 [HTA] 
 
  k2
 k−1
=  
[𝐻𝑇𝐴]
[𝐶 = 𝑂][𝐶𝑦𝑠]
= 𝐊                                                
  k2
 k−1
=  
[𝐻𝑇𝐴]
[𝐶 = 𝑂][BSH]
= 𝐊 
 
  k2
 k−1
=  
753.3
1.24 x 10−5
= 𝟏. 𝟓 ×  𝟏𝟎𝟕                                         
  k2
 k−1
=  
897.4
6.26 x 10−5
= 𝟏. 𝟒 × 𝟏𝟎𝟕 
  
 half-life (t1/2)  
Cys-MG 15 hours 30 minutes 
BS-MG 3 hours and 6 minutes 
(Eq. 2.4) 
(Eq. 2.5) 
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2.5. In vivo analysis of the BSH-dependent glyoxalase pathway 
This research has shown, the in vitro relative reactivity, rate constants and equilibrium 
constants of BSH and Cys reacting with MG. There is now relevance in understanding how 
these results compare with the observations made in vivo. To explore this, the next stage 
was to quantify the intracellular concentrations of Cys and BSH when exposed to excess 
MG, amongst B. subtilis. 
2.5.1. Quantification of intracellular thiols 
To quantify intracellular thiols, Ellman’s reagent is not effective. A standard reagent for 
measuring the intracellular concentrations of thiol is known as monobromobimane (mBBr) 
reagent. It has been widely used for many decades to quantify the intracellular thiol 
concentrations when exposed to a variety of external environmental stresses. Once the 
cells have been stressed with a compound, at different time-points samples of cells can be 
treated with the cell permeable MBBr reagent. The compound selectively reacts with thiols 
in the cell to produce a highly fluorescent and stable thioester (mB-SR) (scheme 2.9).(120) 
However, in this case, it is important to be aware that the formation of HTA from thiol and 
MG, is also a reversible process. Therefore, it is important to determine whether the MBBr 
is detecting the remaining free thiol in the cell, or whether it is also labelling the reversibly 
conjugated BS-MG HTA.  
To investigate this, excess MG (5 mM) was reacted with thiol (100 μM) until complete 
depletion of residual thiol confirmed by Ellman’s assay. The mBBr derivatisation was then 
carried out on the HTA to confirm whether there is a shift in equilibrium detecting the newly 
formed free thiol (scheme 2.10). There was no detection of thiol therefore confirming that 
the mBBr derivatisation process is not detecting the reversibly conjugated BS-MG HTA 
(figure 2.8). This procedure was carried out with both BSH and Cys independently reacting 
with MG, and produced the same result. The importance of this observation, depending on 
the significance of HTA formation, is that these bimane-labelled methods may 
underestimate the true cellular thiol content by only detecting free thiol. 
 
 
 
 
Scheme 2.9. Monobromobimane (mBBr) reacts with thiol to produce monobromobimane thioester which 
if fluorescently active and detected on HPLC.   
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Scheme 2.10. The speculated dissociation of HTA taking place in the mBBr derivatisation process.  
 
     C) 
 
Figure 2.8. HPLC analysis showing A) peak of RSmB B) no peak of RSmB suggesting that there is no 
shift in equilibrium from the mBBr derivatisation process therefore showing that HTA is not derivatised 
C) table of concentration of thiol detected on HPLC. 
 
 
 
Thiol/HTA Time 
(min) 
Ellman’s 
titration 
(μM) 
MBBr 
labelling 
(μM) 
A)Cys 0 109 108 
B)BSH 0 102 99 
A)Cys-MG 30 < 3 < 3 
B)BS-MG 30 < 3 < 3 
A)  CySmB 
A) BSmB 
 
B) CySmB 
B) BSmB 
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2.5.2. Extracellular consumption of methylglyoxal and thiol analysis in B. subtilis 
WT 
Generally, the importance of the RSH-dependent glyoxalase I/II detoxification system is 
signified from the consumption of extracellular concentration of MG and its relation to 
intracellular thiol consumption. It is known that MG is detoxified through many different 
pathways with the RSH-dependent glyoxalase I/II system being the most dominant 
detoxification process.(101) In the WT strain, excess exposure of MG resulted in a stunted 
growth of B. subtilis by at least 3-fold (figure 2.9). The extracellular MG concentration was 
determined at 40-minute intervals using the derivatising agent, 2,4-
dinitrophenylhydrazine(121, 122) (2,4-DNPH) (scheme 2.11). The WT strain had shown the 
fastest depletion of extracellular MG with a rate of 2.96 μM/min resulting in 50% 
consumption after 180 minutes of MG incubation (figure 2.9A). This result is representative 
of the extracellular MG being taken up in the cell and detoxified by the glyoxalase pathway 
and alternative pathways including the glyoxalase III, the aldose reductase and the 
aldehyde dehydrogenase enzymes. 
In parallel, intracellular LMW thiols were quantified using mBBr (120) as previously discussed 
(scheme 2.9). The mBBr derivatisation process was used to determine the reactivity of MG 
with Cys and BSH, at 40-minute intervals. At mid-exponential phase, the BSH content is 
approximately 2.5 μmol/g in B. subtilis WT. As expected, the BSH levels rapidly deplete 
upon exposure to 1 mM MG, where the concentration of BSH decreases to 0.10 μmol/g of 
residual dry weight (RDW). The BSH levels then slowly begin to increase after 120 minutes 
(figure 2.9B). Cys levels were present in lower concentrations relative to BSH showing 
approximately 0.2 μmol/g at mid-exponential phase. Following MG treatment, Cys levels 
rise to 0.6 μmol/g (figure 2.9B). Previous research has shown electrophiles such as MG are 
responsible for an imbalance in thiol-redox homeostasis in B. subtilis because of depletion 
of LMW thiols. (123) This causes an upregulation of a cysteine metabolism repressor, CymR, 
and a global transcriptional regulator, Spx. They both function in the maintenance of thiol 
homeostasis under conditions of electrophile stress and therefore lead to synthesis of 
Cys.(123) 
 
 
 
 
Scheme 2.11. 2,4-Dinitrophenylhydrazine (2,4-DNPH) reacts with MG to form 2,4-dinitrophenylhydrazone 
which is UV-active at 432 nm.  
λ = 432nm 
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Figure 2.9. A) Extracellular consumption of MG after 1 mM incubation in B. subtilis WT (red triangles). 
Representative growth curves are shown for cells grown in absence (blue crosses) and presence 
(orange circles) of MG. B) Cellular BSH and C) Cellular Cys concentration after 1 mM MG incubation in 
B. subtilis WT. Cells are challenged with 1 mM MG (time 0) and harvested at approximately 40 minute 
time points. Cellular BSH levels in the absence (red diamonds) and presence (yellow diamonds) of MG 
and cellular Cys levels in the absence (green circles) and presence (blue circles) of MG which were 
quantified by HPLC after derivatisation with monobromobimane. 
A 
B C 
0.1
1
10
0
200
400
600
800
1000
1200
1400
1600
1800
2000
-100 -50 0 50 100 150 200 250 300
O
D
6
0
0
M
G
 (
μ
M
)
Time (minutes)
B. subtilis WT
with MG
BM media with
MG control
BM media
control
B. subtilis WT
control
B. subtilis WT
growth without
MG
B. subtilis WT
growth with MG
0.01
0.1
1
10
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
5
-100 -50 0 50 100 150 200 250 300
T
h
io
l 
(µ
m
o
l/
g
)
Time (minutes)
BSH levels
without MG
BSH levels with
MG
B. subtilis WT
growth without
MG
B. subtilis WT
with MG
O
D
6
0
0
A 
B 
0.01
0.1
1
10
0
0.5
1
1.5
2
2.5
3
3.5
4
4.5
5
-100 -50 0 50 100 150 200 250 300
T
h
io
l 
(µ
m
o
l/
g
)
Time (minutes)
Cys levels
without MG
Cys levels with
MG
B. subtilis WT
growth without
MG
B. subtilis WT
with MG
O
D
6
0
0
C 
61 
 
2.5.3. Immediate in vivo kinetics of thiol reactivity with MG in B. subtilis WT 
After the cells are exposed to MG, there is approximately a 15-minute experimental delay 
for harvesting the cell pellets before the intracellular thiol is labelled with the mBBr reagent. 
This in turn allows ample opportunity for MG and thiol to react before the thiol concentration 
is determined and as a result, the initial reactivity could not be observed, in vivo. So, this 
initial reactivity was observed by streamlining the experimental process, allowing a more 
frequent quenching of mBBr with cell pellets. The in vitro kinetics show a full consumption 
of BSH in a matter of seconds when treated with excess MG. The in vivo kinetics, however, 
show the full consumption of BSH is not immediate, which is possibly explained by the time-
lag for the MG to present intracellularly. This is indicated by the time-point at 6 minutes after 
MG exposure which shows the intracellular concentration has decreased from 3.8 μmol/g 
to 0.6 μmol/g. However, it further decreases to a lower concentration of approximately 0.2 
μmol/g, at 22 minutes (figure 2.10A). The levels begin to gradually increase showing that 
the BSH is being recycled through the glyoxalase pathway (figure 2.10B).  
 
 
 
Figure 2.10. The immediate effect of the addition of 1 mM MG on BSH concentration. A) Full graph. B) 
Recovery of BSH. 
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2.5.4. Extracellular consumption of methylglyoxal and thiol analysis in B. subtilis 
glxI mutant 
One potentially effective way of determining the efficiency of the glyoxalase system in the 
cells of B. subtilis was to analyse and compare the extracellular consumption of the WT to 
the mutant strains including glxI, glxII and BSH-null mutants.  
The GlxI catalyses the isomerisation of HTA to S-D-lactoyl-BSH in the first step of the 
detoxification (scheme 2.12). It has previously been reported that the glxI mutant shows an 
increased sensitivity to MG, which correlates with the persistence of the MG in the growth 
medium.(101) Extracellular consumption of MG took place at a rate of 0.96 μM/min (figure 
2.11A). There is a clear reduction in extracellular consumption of MG shown by the 
decreased rate of uptake into the cell relative to the WT strain. In relation to the thiol levels, 
the BSH levels are rapidly consumed (95% depletion) over the first 15 minutes (figure 
2.11B). However, after 100 minutes of MG incubation there is shown to be a recovery of 
BSH. This confirms the equilibrium between MG and HTA where the dissociation of HTA is 
taking place forming the free BSH. There is no effect on Cys levels suggesting BSH is the 
predominant thiol involved in this first step of detoxification (figure 2.11C).   
 
Scheme 2.12 Chemical scheme of the glxI mutant glyoxalase pathway. 
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Figure 2.11 A) Extracellular consumption of MG after 1 mM incubation in B. subtilis glxI mutant (red 
triangles). Representative growth curves are shown for cells grown in absence (blue crosses) and 
presence (orange circles) of MG. B) Cellular BSH and C) cellular Cys concentration after 1 mM MG 
incubation in B. subtilis glxI mutant. Cells are challenged with 1 mM MG (time 0) and harvested at 
approximately 40-minute time points. Cellular BSH levels in the absence (red diamonds) and presence 
(yellow diamonds) of MG and cellular Cys levels in the absence (green circles) and presence (blue 
circles) of MG.   
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2.5.5. Extracellular consumption of methylglyoxal and thiol analysis in B. subtilis 
glxII mutant 
The GlxII is responsible for converting the S-D-lactoyl BSH to D-lactate and the BSH is 
recycled (scheme 2.13). The extracellular detoxification of MG was shown to be faster than 
the glxI mutant with a rate of consumption of 1.72 μM/min (figure 2.12A). It was speculated 
that the extracellular MG would be consumed at a faster rate as the HTA is no longer in 
equilibrium with MG and free thiol. Thiol quantification shows BSH levels to be rapidly 
consumed which then persist at a low concentration (figure 2.12B). This confirms that the 
GlxI catalysed isomerisation is irreversible, hence, the BSH is trapped as S-D-lactoyl-BSH. 
It also proves that the GlxII enzyme is responsible for the recycling of BSH. The Cys levels 
were found to slightly reduce upon treatment with MG to 0.2 μmol/g (figure 2.12C). It is 
possible that the Cys is now reacting with MG due to the full depletion of the unrecoverable 
BSH.  
 
Scheme 2.13. Chemical scheme of the glxII mutant glyoxalase pathway. 
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Figure 2.12. A) Extracellular consumption of MG after 1 mM incubation in B. subtilis glxII mutant (red 
triangles). Representative growth curves are shown for cells grown in absence (blue crosses) and 
presence (orange circles) of MG. B) Cellular BSH and C) cellular Cys concentration after 1 mM MG 
incubation in B. subtilis glxII mutant. Cells are challenged with 1 mM MG (time 0) and harvested at 
approximately 40-minute time points. Cellular BSH levels in the absence (red diamonds) and presence 
(yellow diamonds) of MG and cellular Cys levels in the absence (green circles) and presence (blue 
circles) of MG.  
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2.5.6. Extracellular consumption of methylglyoxal and thiol analysis in B. subtilis 
glxI/II mutant 
As anticipated, the glxI/II mutant essential shows the same results as the glxI mutant with 
the extracellular MG consumption taking place at a slightly slower rate than glxI mutant at 
0.81 μM/min (figure 2.13A). The absence of the GlxII enzymes becomes irrelevant when 
the GlxI enzymes are not present to continue the process of detoxification. Similarly to glxI 
mutant, there is shown to be a recovery of BSH, again confirming that an equilibrium is 
formed between the MG and the HTA (figure 2.13B).  
 
Scheme 2.14. Chemical scheme of the glxI/II mutant glyoxalase pathway. 
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Figure 2.13. A) Extracellular consumption of MG after 1 mM incubation in B. subtilis glxI/II mutant (red 
triangles). Representative growth curves are shown for cells grown in absence (blue crosses) and 
presence (orange circles) of MG. B) Cellular BSH and C) cellular Cys concentration after 1 mM MG 
incubation in B. subtilis glxI/II mutant. Cells are challenged with 1 mM MG (time 0) and harvested at 
approximately 40-minute time points. Cellular BSH levels in the absence (red diamonds) and presence 
(yellow diamonds) of MG and cellular Cys levels in the absence (green circles) and presence (blue 
circles) of MG. 
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2.5.7. Extracellular consumption of methylglyoxal and thiol analysis in B. subtilis 
bshC mutant 
A BSH-null mutant was achieved by the knock-out of the third biosynthetic gene, bshC, 
necessary for the biosynthesis of BSH. Regarding the bshC mutant, the metabolite cannot 
be detoxified through the glyoxalase pathway (scheme 2.15). As expected, there was found 
to be no BSH in the thiol analysis (figure 2.14B). As a result, the Cys concentration remained 
constant and did not deplete even in the absence of BSH (figure 2.14C). This suggests that 
Cys has no involvement in the detoxification of MG in the cell, despite the fact the in vitro 
kinetics represent reactivity. It is also suggestive that the extracellular consumption, at a 
slower rate of 0.77 μM/min, relative to all other mutant strains, is a result of thiol-
independent detoxification pathways including the MG reductase and dehydrogenase 
enzymes (figure 2.14A). Therefore, this data shows the thiol-dependent glyoxalase pathway 
is not essential for the survival of the cell.  
 
 
Scheme 2.15. Chemical scheme of BSH-null mutant and alternative detoxification pathways. 
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Figure 2.14 A) Extracellular consumption of MG after 1 mM incubation in B. subtilis bshC mutant (red 
triangles). Representative growth curves are shown for cells grown in absence (blue crosses) and 
presence (orange circles) of MG. B) Cellular BSH and C) Cys concentration after 1 mM MG incubation 
in B. subtilis bshC mutant. Cells are challenged with 1 mM MG (time 0) and harvested at approximately 
40-minute time points. Cellular BSH levels in the absence (red diamonds) and presence (yellow 
diamonds) of MG and cellular Cys levels in the absence (green circles) and presence (blue circles) of 
MG.  
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Figure 2.15. The rate of extracellular consumption of MG upon 1mM incubation in B. subtilis WT and 
KO. 
2.5.8. B. subtilis WT, glxI, glxII, bshC mutant growth curves in LB media and 
minimal media 
The growth curves in LB media are represented for all B. subtilis strains (figure 2.16). In the 
absence of MG, the mutant strains show similar growth to the WT. At an OD600 of 0.7, cells 
were incubated with 1 mM MG, all six strains show susceptibility to MG represented by a 
stunted growth. However, there is continued growth in all strains including the BSH-null 
mutant, which highlights that BSH is not essential for cell growth in both physiological 
conditions and when incubated with excess MG. The growth of all the strains were found to 
significantly differ when grown in Belitsky minimal (BM) media, with late-exponential phase 
reaching an approximate OD600 of 3 (figure 2.17). 
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Figure 2.16. B. subtilis growth in the presence and absence of 1 mM MG in LB media. 
 
Figure 2.17. B. subtilis growth in the presence and absence of 1 mM MG in Belitsky minimal (BM) media. 
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2.5.9. Effect of different MG stress on growth of B. subtilis WT and bshC mutant  
As previously discussed, 1 mM MG was shown to stunt growth of B. subtilis, however, the 
cells continue to grow. To further this investigation, the potency of MG in both B. subtilis WT 
and bshC mutant was determined by monitoring the growth using various different 
concentrations of MG (figure 2.18).  
 
Figure 2.18: Different inoculation of MG concentration on A) B. subtilis WT and B) bshC mutant. 
The growth of the WT and bshC mutant are found to be similar. Upon incubation of MG, an 
increasing MG concentration results in a reduced growth of B. subtilis. 1 mM MG incubation 
results in a higher growth rate in the WT than the BSH mutant. This is also observed with 2 
mM MG incubation. However, when incubated with concentrations above 2 mM MG, there 
was no further growth of bacteria resulting in the death phase (figure 2.18). Research has 
previously shown that lethal levels of MG are known to be approximately 0.6 mM over 6 
hours in E. coli.(104) However, this was not observed in the 4-hour period of growth of the 
mutant strains. A possible reason for this is the different strains of bacteria being analysed.  
It was speculated that the BSH mutant would show more susceptibility to MG as there is no 
possible MG detoxification through the BSH-dependent glyoxalase pathway. However, both 
strains showed a similar response to the specified amount of MG inoculation, which 
demonstrates the non-essential nature of this pathway for MG detoxification.   
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2.5.10. Carbohydrate stress on B. subtilis WT and bshC mutant strain 
In general, bacteria are diverse in nature and have the ability to thrive under different 
environmental conditions. There is particular interest on carbohydrate-rich condition, as it 
is speculated that under these conditions, glycolysis metabolism increases resulting in a 
higher production of MG, as a by-product. Therefore, there is relevance in confirming this 
accumulation of MG amongst B. subtilis. 
The B. subtilis WT growth significantly increases in media supplemented glucose 0.5%/ 
arabinose 0.5%, reaching an OD600 of above 6 at late-exponential phase. B. subtilis cells 
readily utilise the glucose reaching an OD600 of 4 at 600 minutes. This is followed by the 
stationary phase suggesting a full consumption of glucose. The growth then resumes after 
1400 minutes, which is possibly explained by the cells now using the arabinose as the main 
source of energy.  With a further growth to approximately an OD600 of 6, there is a significant 
increase in MG levels. The WT released 90 μM of potential MG in the medium in comparison 
to 20 μM MG in the absence of the carbohydrate (figure 2.19A). It is clear that a direct stress 
of carbohydrate results in an increased workload for glycolysis resulting in a higher 
production of MG. This suggests that the growth of B. subtilis WT is limited by the lack of 
carbohydrate sources. These data therefore suggest that MG has potential to exist in 
moderately high concentrations in the cell which explains the importance of the 
detoxification routes of this metabolite.   
 
Figure 2.19: Effect of carbohydrate stress upon the levels of MG for B. subtilis WT. Representative 
growth curves are shown in the absence (blue) and presence (orange) of glucose 0.5%/arabinose 0.5% 
stress. The extracellular MG concentration in the absence (dark blue crosses) and presence (dark red 
circles) of glucose 0.5%/arabinose 0.5% stress which were derivatised with 2, 4-dinitrophenylhydrazine.  
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2.6. Summary 
Cys and BSH have been shown to possess a similar reactivity with MG when comparing 
their thiolate. However, the thiol pKa of BSH is lower than Cys and therefore more 
deprotonated at physiological conditions. As a result, there is more BSH thiolate resulting 
in a faster reactivity relative to Cys, both of which are > 100-fold more reactive than GSH 
and CysNAc. Using the rate constants of the reaction between BSH and MG, the predicted 
equilibrium constant was found to favour the forwards reaction highlighting that the HTA 
may be present in high intracellular concentrations relative to the reactants. 
The in vivo studies provided more evidence of BSH involvement in the detoxification of MG. 
B. subtilis WT upon incubation with 1 mM MG, resulted in an extracellular consumption of 
MG, in parallel to a full depletion of intracellular BSH. All mutant strains showed extracellular 
consumption of MG including the BSH-null mutant strain at a slower rate, indicating the 
thiol-independent detoxification pathways are taking place. In addition, as anticipated, the 
glxI mutant showed recovery of BSH whilst the glxII mutant showed no recovery of BSH. All 
this data is suggestive that the role of BSH in B. subtilis is analogous to the role of GSH in 
the thiol-dependent glyoxalase pathway amongst eukaryotes. To further this investigation, 
the extracellular MG was analysed under carbohydrate rich and famine conditions, where 
MG was produced approximately 5-fold higher in a carbohydrate rich environment.  
MG remains a prominent toxic metabolite formed as a by-product of glycolysis, in 
intracellular concentrations up to 1.5 mM.(57) The studies show strong evidence that BSH is 
the dominant LMW thiol in the detoxification of MG amongst B. subtilis. In addition, the 
reaction kinetics show BSH to be a strong nucleophile, present in high intracellular 
concentrations. This therefore questions the possibility of BSH reactivity with other 
carbonyl-containing metabolites present in the cell. Past research has investigated the 
reactivity of Cys with other carbonyl-containing molecules including acetone, acetaldehyde 
and formaldehyde.(124) Current literature has shown that the equilibrium constant for thiol 
with acetone is 100-fold smaller than acetaldehyde which is 20-fold smaller than 
formaldehyde.(124) Therefore, there is now considerable interest in investigating the 
interaction of BSH with other electrophilic chemical species, in particularly, the glycolytic 
metabolites. 
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3. The glycolytic metabolites and their interaction 
with low molecular weight thiols 
 
3.1. Overview 
The involvement of BSH and Cys in the reactivity with MG has been explored. There is now 
a clear progression to determine the reactivity of LMW thiols with other intracellularly 
carbonyl-containing species, with the main focus on the glycolytic metabolites.  
3.2. Glycolysis  
Glycolysis consists of 10 enzyme-catalysed reactions (figure 3.1), which can be broken 
down into two phases. The first phase encompasses the first five reactions. Glucose, the 
main carbohydrate source, is phosphorylated to form glucose 6-phosphate (G6P). G6P is 
then isomerised to produce fructose 6-phosphate (F6P) and subsequently phosphorylated 
to produce fructose 1,6-bisphosphate (F1,6-BP). F1,6-BP is then split into two 3-carbon 
sugars, dihydroxyacetone phosphate (DHAP) and D-glyceraldehyde 3-phosphate (GA3P). 
The next five reactions comprise the second phase of glycolysis, which is called the ‘payoff’ 
phase because two high-energy phosphate bonds are produced herein. In this phase, 
GA3P loses two electrons and two protons reducing NAD+ to NADH producing 1,3-
bisphospho-D-glycerate (1,3-BPG). 1,3-BPG then donates a phosphate group to ADP 
producing 3-phospho-D-glycerate (3-PG) and ATP, which is then isomerised to 2-phopho-
D-glycerate (2-PG). A dehydration step then produces phosphoenolpyruvate (PEP) which 
then loses a phosphate group to produce the final product, pyruvate (figure 3.1).  
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Scheme 3.1. The glycolytic pathway. 1) Hexokinase 2) phosphoglucoisomerase 3) phosphofructokinase 
4) aldolase 5) triose phosphate isomerase 6) GA3P dehydrogenase 7) phosphoglycerokinase 8) 
phosphoglyceromutase 9) enolase 10) pyruvate kinase. In addition to the metabolism of DHAP to MG 
and glyoxalase pathway A) MG synthase B) glyoxalase I and II C) lactate dehydrogenase. 
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3.2.1. Potential reactivity of glycolytic metabolites  
The metabolites of the first phase of glycolysis, consist of glucose, G6P, F6P and F1,6-BP, 
which all possess carbonyls in their open chain structure with approximately 0.004% in this 
form (scheme 3.2).(125) The majority of these sugars exist in their unreactive cyclic form. 
However, the open chain form and cyclic form are in equilibrium and therefore there is 
potential for reactivity of thiol to take place with the reactive carbonyl. However, the second 
phase metabolites of glycolysis possess electrophilic groups including aldehydes, ketones 
and Michael acceptors which are also less sterically hindered. They are more likely to 
undergo a nucleophilic attack from LMW thiols and therefore the focus will be on the second 
phase metabolites.  
Past research has established that Cys and GSH react with various metabolites of 
glycolysis; Cys (10 mM) was shown to react with pyruvate (1 mM), pH 7.3, 20 °C, with 50% 
consumption after the first minute.(126) In addition, GSH (400 mM) was shown to react with 
GA3P (400 mM), pH 4-5, 25 °C, for 10 minutes, showing formation of HTA.(127) Therefore, 
evidence has shown previous reactivity of thiol and glycolytic metabolite, however, these 
high concentrations used do not represent physiological conditions. 
The reactivity of BSH and Cys with carbonyl-containing metabolite were determined, 
focusing on the second phase metabolites. These include D-glyceraldehyde 3-phosphate 
(GA3P), dihydroxyacetone phosphate (DHAP), phosphoenolpyruvate (PEP), and pyruvate 
(scheme 3.1). The potential reactivity has scope to newly identify unknown reactions taking 
place in the cell whilst also exploring additional functions of BSH as a chemical scavenger. 
Scheme 3.2. First phase metabolites in their closed-ring and open-ring form. 
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3.2.2. Dihydroxyacetone phosphate and D-glyceraldehyde 3-phosphate 
The second stage of glycolysis begins with the splitting of fructose 1,6-bisphosphate into 
the triose phosphates, DHAP and GA3P, catalysed by fructose 1,6-bisphosphate aldolase 
(scheme 3.1). They are isomers of each other, where their interconversion is catalysed by 
triose phosphate isomerase (TIMs). This enzyme is a key component of glycolysis found to 
accelerate the isomerisation by a factor of 109 relative to non-enzyme catalysis.(128) The 
triose phosphates are problematic to the cell if allowed to accumulate as they contain a 
phosphate group, which can therefore cause phosphate starvation within the cell. The 
phosphate can be liberated, either non-enzymatically(77)  or enzymatically catalysed by MG 
synthase, to form MG.(73-75)  Alternatively, GA3P is metabolised through glycolysis to 
eventually produce pyruvate (scheme 3.3).  
Both DHAP and GA3P are found to be unstable under physiological conditions due to the 
chemical breakdown of the triose phosphate to MG.(71, 82) Control assays have shown the 
degradation of DHAP and GA3P to be 0.8 μmol/min and 2.7 μmol/min, respectively (figure 
3.1). After 300 minutes, the DHAP concentration decreases from 3.8 mM to 3.6 mM 
representing at 5% decrease whilst the GA3P concentration decreases from 3.5 mM to 2.6 
mM, representing a 26% decrease. The assays investigating the initial reactivity were 
carried out in a 10-30 minute time-frame and therefore are unlikely be affected by the 
possibly degradation of DHAP/GA3P to MG. However, the assays determining the steady-
state equilibria for determination of the equilibrium constants (chapter 3.5) were carried out 
over a longer time-frame. 
 
 
 
 
 
 
 
 
Figure 3.1. Controls of DHAP and GA3P stability in 50 mM HEPES buffer, pH 7.7, 20 °C. 
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Scheme 3.3. The three ways of triose phosphate metabolism. A) GA3P forms 1,3-bisphosphoglycerate 
and proceeds through glycolysis to form pyruvate. B) The breakdown of the triose phosphate which 
non-enzymatically degrades to form an enediolate intermediate, and the MG. C) The enzymatically 
catalysed reaction of DHAP to form MG, via MG synthase.  
3.3.3. Reactivity of glycolytic metabolites with LMW thiols   
DHAP, GA3P, PEP and pyruvate (1500 μM) of the second phase of glycolysis (scheme 3.1) 
were reacted with thiol (3 mM Cys, 2 mM BSH, 8 mM GSH) for 30 mins at 20 °C, pH 7.7, to 
determine the possible reactivity at physiological conditions (table 3.1). The other remaining 
metabolites of the second phase of glycolysis, 1,3-bisphosphogylcerate, 3-
phosphoglycerate, 2-phosphoglycerate, contain no reactive carbonyl groups and therefore 
no reactivity with LMW thiols will be observed.  
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Phosphoenolpyruvate (PEP) is an α, β-unsaturated carbonyl compound and can potentially 
undergo a Michael addition reaction with the thiol nucleophile being the Michael donor. 
There was, however, no reactivity observed between this metabolite and thiol. Similarly, 
there was no reactivity of thiol with pyruvate (1500 μM), but in excess pyruvate (10 mM), 
BSH and Cys were shown to react as discussed in chapter 3.4. 
DHAP and GA3P were both found to react with Cys and BSH, in the preliminary 
investigation (table 3.1). Therefore, pseudo first order reaction conditions were implemented 
to compare reactivity. Metabolite (10 mM) was reacted with thiol (3 mM Cys, 2mM BSH) at 
20 °C, pH 7.7. 3 mM Cys and 2 mM BSH both equate to 0.44 mM of thiolate. The relative 
reactivity of BSH to Cys was approximately the same, with both thiols reacting significantly 
faster with GA3P than DHAP, by approximately 3-fold (figure 3.2). Both Cys and BSH 
reacting with DHAP showed 40% reactivity after 30 minutes whilst the GA3P showed > 95 
% reactivity (figure 3.2A/B). This reaction continued for 4 hours with DHAP until a full 
depletion of the thiols. The difference in reactivity is thought to arise because of the more 
reactive electrophilic aldehyde group that GA3P possesses as opposed to the ketone group 
on DHAP.   
Table 3.1. Initial screening reactivity of thiol cofactors and metabolites, pH 7.7, at 20 °C. 
Metabolite Cys (3 mM) BSH (2 mM) GSH (8 mM) 
DHAP (1500 μM) 
 
✔ ✔ X 
GA3P (1500 μM) 
 
✔ ✔ X 
PEP (1500 μM) 
 
X X X 
Pyruvate (1500 μM) 
 
✔1* ✔1* X 
1*Initial reactivity was only determined in excess pyruvate (10 mM) and thiol (3 mM Cys, 2 mM BSH), pH 7.7, 20 °C 
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Whilst these preliminary experiments demonstrate comparable reactivity between Cys and 
BSH thiolates with DHAP and GA3P, they are not necessarily a true reflection of their 
potential significance in the intracellular setting. In vivo, DHAP and GA3P are constantly 
being consumed and produced. In addition, intracellular BSH is often more abundant than 
Cys in B. subtilis. So, the concentrations of metabolites and thiols as well as the intracellular 
pH vary under different cellular conditions. Therefore, determination of the pH-independent 
rate constants and equilibrium constants would provide a more informative set of values 
that could be used to assess the significance of these reactions in different physiologically 
relevant conditions.  
 
Figure 3.2. The relative reactivity of DHAP and GA3P (10 mM) with A) Cys (3 mM) for 30 mins B) BSH (2 
mM) for 30 mins, C) Cys (3 mM) for 2 mins and D) BSH (2 mM) for 2 mins, at 20 °C, HEPES (50 mM) pH 
7.7. Data was carried out in duplicate where error bars show ± SEM. 
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3.3. pH-dependent (pH 7.7) and pH-independent rate constants 
3.3.1. Forwards and reverse rate constants for the reactivity of DHAP with thiols 
The pH-independent pseudo-first order rate constants (k1) were determined for the reactivity 
of DHAP and GA3P with both, Cys and BSH. The rate of HTA formation by reaction from 
the reaction between Cys and DHAP increased linearly up to 0.75 mM. The rate of reaction 
above this value was found to decrease relative to the concentration. This is possibly due 
to the first order reaction becoming a second order reaction or possibly because of 
experimental error shown by a large SEM in the last two data points, at thiol concentration 
1200 μM and 1600 μM (figure 3.3C).(108) The rate constant was determined from the linear 
region of the graph where it appeared to be following pseudo-first order kinetics, which was 
found to be 6 x 10-4 s-1 at pH 7.7, whilst the pH-independent constant was found to be 4.4 
x 10-3 s-1.  
The rate constant for HTA formation between BSH with DHAP was found to be 7 x 10-4 s-1 
at pH 7.7, and therefore possesses a similar reactivity to Cys reacting with DHAP (figure 
3.3C/D). However, due to the higher thiol pKa of Cys, there is less Cys- thiolate relative to 
BS- thiolate at pH 7.7. As a result, the pH-independent rate constant for BS- reacting with 
DHAP was 3.1 x 10-3 s-1, which is found to be 1.4 times slower than the Cys and DHAP pH-
independent rate constant. In addition, the second order rate constants were determined 
by dividing the pseudo-first order rate constant by the DHAP concentration (0.01 M) (table 
2.2). 
The reverse rate constants were determined following the same technique investigating the 
dissociation of the RS-MG HTA (chapter 2.2.3). The reverse rate constants were found to 
be approximately 100 times less than the forwards rate constant. The dissociation for both 
Cys-DHAP and BS-DHAP HTA took place in a similar manner (figure 3.4) Whilst both Cys 
and BSH have shown to possess similar rates of reaction with DHAP, BSH is found to be 
present at higher intracellular concentrations of approximately 3 mM as opposed to 
approximately 0.2 mM of Cys, at late exponential phase of B. subtilis growth. Therefore, the 
potential BS-DHAP HTA is more likely to be present in a higher concentration than the Cys-
DHAP HTA.    
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Forwards rate constant for thiol and DHAP 
 
Figure 3.3. A)  The consumption of Cys (200 μM – 1600 μM) with DHAP (10 mM) in HEPES (50 mM), pH 7.7, 20 °C, 
representing pseudo first order reaction kinetics with each gradient representing the rate of reaction. B) The 
consumption of BSH (200 μM – 1600 μM) with DHAP (10 mM) in HEPES buffer (50 mM), pH 7.7, 20 °C, representing 
pseudo first order reaction kinetics with each gradient representing the rate of reaction. C) The two rate constants 
of DHAP reactivity with Cys/BSH, at pH 7.7 D) The two pH independent rate constants of DHAP reactivity with 
Cys/BSH. Data was carried out in duplicate where error bars show ± SEM. 
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Reverse rate constants for thiol and DHAP 
 
 
 
 
 
 
 
 
Figure 3.4. A)  The dissociation of HTA (125 μM – 750 μM) using DTNB (2 mM) in HEPES buffer (50 mM) pH 7.7, 20 °C, 
over 500 seconds after carrying out an initial reaction of Cys (5 mM) with DHAP (10 mM) in HEPES buffer (50 mM), 
pH 7.7, 20 °C, with each gradient representing the rate of reaction. B) The dissociation of HTA (125 μM – 500 μM) 
using DTNB (2 mM) in HEPES buffer (50 mM) pH 7.7, 20 °C, over 250 seconds after carrying out an initial reaction of 
BSH (5 mM) with DHAP (10 mM) in HEPES buffer (50 mM), pH 7.7, 20 °C, with each gradient representing the rate of 
reaction. C) The two dissociation rate constants of HTA to form DHAP and Cys/BSH, at pH 7.7. Data was carried out 
in duplicate where error bars show ± SEM. 
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3.3.2. Forwards and reverse rate constants for the reactivity of GA3P and thiols  
Rate constants for the interaction between thiol and GA3P were found to show a faster rate 
of reaction relative to DHAP by approximately 2-fold (table 3.2). The BSH was found to react 
1.3 times faster than Cys with GA3P, at pH 7.7 (figure 3.5C). Yet, considering the higher 
thiol pKa of Cys, the pH-independent rate constant was 1.1 times faster for the Cys- relative 
to the BS- (figure 3.5D). However, in general, there is only a slight difference in reactivity 
between the rates of Cys and BSH reacting with GA3P, which agrees with the initial relative 
rate of reactions observed (table 3.2).  
The dissociation of HTA takes place in a similar rate for both DHAP-SR and GA3P-SR. 
However, the reverse rate constant for GA3P-SR (figure 3.6) was found to be approximately 
200-times less than the forwards rate constant (figure 3.5). The half-life of each dissociation 
reaction were all greater than 24 hours suggesting that the forward reaction dominates 
(table 3.3). 
Table 3.2: Pseudo first order rate constant (k1), second order rate constant (k2) and reverse rate (k-1) 
constants for HTA formation from Cys and BSH reactivity with DHAP/GA3P  
 Rate constant  pH 7.7a 
(± SEM) 
pH-independent rate constant 
(± SEM) 
Pseudo-first order rate constant (k1) with respect to thiol 
Cys-DHAP 6 x 10-4 s-1         (±1.5 x 10-4)          4.4 x 10-3 s-1      (±1.1 x 10-4) 
BS-DHAP 7 x 10-4  s-1        (±1 x 10-4) 3.1 x 10-3 s-1      (±4.5 x 10-4)   
Cys-GA3P 1.1 x 10-3 s-1     (±1 x 10-4) 7.3 x 10-3 s-1     (±5 x 10-4)        
BS-GA3P 1.4 x 10-3 s-1     (±5 x 10-5) 6.6 x 10-3 s-1    (±1.5 x 10-4) 
Second order rate constant (k2) 
Cys-DHAP 0.06 M-1s-1      (±0.015) 0.44 M-1s-1      (±0.011) 
BS-DHAP 0.07 M-1s-1      (±0.01) 0.31 M-1s-1      (±0.045) 
Cys-GA3P 0.11 M-1s-1      (±0.01) 0.73 M-1s-1      (±0.05) 
BS-GA3P 0.14 M-1s-1      (±0.005) 0.66 M-1s-1      (±0.015) 
Reverse rate constant (k-1) 
Cys-DHAP 7 x 10-6  s-1   (±1.1 x 10-6) - 
BS-DHAP  5.6 x 10-6 s-1   (±5 x 10-7)    - 
Cys-GA3P 6 x 10-6 s-1   (±7.5 x 10-7)      - 
BS-GA3P 8 x 10-6 s-1   (±5 x 10-7) - 
aRate constant could not be determined at this pH because of the speed of the reaction and therefore the rate 
constant has been calculated based on the thiolate concentrations at pH 7.7 relative to pH 5.6. 
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Table 3.3. The half-life for the dissociation of HTA to form free thiol and DHAP/GA3P. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Half-life (t1/2)  
Cys-DHAP 27 hours 30 minutes 
BS-DHAP 34 hours and 24 minutes 
Cys-GA3P 32 hours and 6 minutes 
BS-GA3P 24 hours and 6 minutes 
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Forwards rate constant for thiol and GA3P  
 
Figure 3.5. A)  The consumption of Cys (200 μM – 1600 μM) with GA3P (10 mM) in HEPES buffer (50mM), pH 7.7, 20 
°C, representing pseudo first order reaction kinetics with each gradient representing the rate of reaction. B) The 
consumption of BSH (200 μM – 1600 μM) with DHAP (10 mM) in HEPES buffer (50mM), pH 7.7, 20 °C, representing 
pseudo first order reaction kinetics with each gradient representing the rate of reaction. C) The two rate constants 
of GA3P reactivity with Cys/BSH, at pH 7.7 D) The two pH independent rate constants of GA3P reactivity with 
Cys/BSH. Data was carried out in duplicate where error bars show ± SEM. 
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Reverse rate constant for thiol and GA3P 
A)                                                                                  B) 
                                              
 
 
 
 
 
 
Figure 3.6. A)  The dissociation of HTA (125 μM – 1000 μM) using DTNB (2 mM) in HEPES buffer (50 mM) pH 7.7, 20 
°C, over 500 seconds after carrying out an initial reaction of Cys (5 mM) with GA3P (10 mM) in HEPES buffer (50mM), 
pH 7.7, 20 °C, with each gradient representing the rate of reaction. B) The dissociation of HTA (125 μM – 750 μM) 
using DTNB (2 mM) in HEPES buffer (50 mM) pH 7.7, 20 °C, over 250 seconds after carrying out an initial reaction of 
BSH (5 mM) with GA3P (10 mM) in HEPES buffer (50mM), pH 7.7, 20 °C, with each gradient representing the rate of 
reaction.  C) The two dissociation rate constants of HTA to form GA3P and Cys/BSH, at pH 7.7. Data was carried out 
in duplicate where error bars show ± SEM. 
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3.4. Reactivity of thiol and pyruvate 
It has been established that pyruvate is present in the cell at high concentrations (> 10 mM) 
in B. subtilis when in malate and glucose rich conditions.(129) Therefore, reactions were 
carried out implementing new assay conditions. This included the reactivity of thiol (2 mM 
Cys, 3 mM BSH, 8 mM GSH) with a higher concentration of pyruvate (10 mM) regulated at 
pH 7.7, 20 °C. As a result, reactivity was observed with both Cys and BSH (figure 3.7). The 
reactivity of pyruvate with Cys and BSH is found to be approximately 7-fold and 4-fold slower 
than with DHAP, respectively. Whilst the rates of reactivity are slower, pyruvate exists in up 
to a concentration of 145.01 mM(129) in the cell and therefore there is potential for the 
pyruvate-SB HTA to form in a significant concentration.  
 
 
 
 
 
 
 
 
 
 
Figure 3.7. The reaction of 2 mM Cys, 3 mM BSH and 8 mM GSH with 10 mM Pyruvate in HEPES buffer, 
pH 7.7, 20 °C, representing the same thiolate concentration (0.44 mM).  
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3.5. Thermodynamics – equilibrium constant (Keq) 
3.5.1. Overview 
The forwards and reverse rate constants have now been determined and prove that an 
interaction takes place between the thiol and metabolite. However, the significance of these 
reactions is yet to be determined. This is dependent firstly on the concentrations that the 
cofactors and metabolites are present in the cell and secondly on the equilibrium constants 
(Keq) of the reaction.  
There are 2 distinctive methods for the determination of the equilibrium constant that have 
been implemented in this research. The first method uses the rate constants of the reaction 
between thiol and metabolite reactivity. k-1 and k2 are both constants where the ratio (k2/k-1) 
represents the equilibrium constant (Keq) (equation 3.5). The second method involves 
quantification of thiol, metabolite and HTA directly at equilibrium, and when represented in 
the form of equation 3.6, produces the Keq.  
Method 1: The rate constants of the forward reaction against the reverse reaction produces 
the equilibrium constant (Keq): 
𝐾𝑒𝑞 =
𝑘2
𝑘−1
 
Method 2: The reaction of metabolite and thiol in different ratios each produces a steady 
state. At steady state, the concentrations of HTA against the concentration of thiol and 
metabolite produces the equilibrium constant (Keq): 
𝐾𝑒𝑞 =
[𝐻𝑇𝐴]
[𝐶 = 𝑂][𝑅𝑆𝐻]
 
 
 
 
 
 
 
 
 
Eq. 3.5 
Eq. 3.6 
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DHAP equilibrium constant (Keq) 
A)                  B) 
GA3P equilibrium constant (Keq)    
B)                                                                    D) 
 
Figure 3.8. A) Reactivity of different ratios of thiol to metabolite (2:1 (3 mM: 1.5 mM), 7:4 (3 mM: 1.7 mM), 
3:2 (3 mM: 2 mM), 5:4 (3 mM, 2.4 mM), 4:5 (3 mM, 3.75 mM), 1:1 (3 mM: 3 mM) in 50 mM HEPES pH 7.7, 
under nitrogen conditions) to determine state of equilibrium and equilibrium constant (Keq) ± SEM in A) 
Cys and DHAP. B) BSH and DHAP. C) Cys and GA3P. D) BSH GA3P. 
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3.5.2. Method 2 - Calculation of equilibrium constant (Keq) example 
Table 3.4: The first set of Keq found from the reaction between Cys and DHAP. The reaction of the 5:4 
ratio of RSH:C=O is used as an example for the determination of Keq.  
Ratio 
RSH:C=O 
[Cys0] 
mM 
[Cyst] 
mM 
[DHAPt] 
mM 
[HTA] 
mM 
Keq 
5:4 3.08 0.72 0.65 2.36 5.04 
3:2 3.12 1.03 0.51 2.09 4.00 
7:4 3.09 1.33 0.26 1.76 5.16 
2:1 3.10 1.52 0.22 1.58 4.70 
 
Ellman’s titration was carried out at t = 0 to quantify the starting concentration of thiol 
(RSH0). Once equilibrium had been met, Ellman’s titration was carried out again to quantify 
the concentration of thiol at equilibrium (RSHt). In parallel to this, DHAP was quantified using 
the DHAP assay (chapter 6.5.2.1) when the equilibrium had been met to determine the 
concentration of residual concentration of DHAP (DHAPt).  
The following equation was then used to calculate the Keq 
𝐾𝑒𝑞 =
[𝐻𝑇𝐴]
[𝐷𝐻𝐴𝑃][𝑅𝑆𝐻]
 
𝐾𝑒𝑞 =
[𝑅𝑆𝐻0 − 𝑅𝑆𝐻𝑡]
[𝐷𝐻𝐴𝑃𝑡][𝑅𝑆𝐻𝑡]
 
𝐾𝑒𝑞 =
[3.08 − 0.72]
[0.65][0.72]
 
𝐾𝑒𝑞 = 5.04 
This calculation was carried out for every data value which had been recorded at equilibrium 
(table 3.4). Then the mean of all these reactions were then calculated for each set of 
reactions, in this instance, the DHAP and Cys reaction. The Keq achieved represents the 
mean value with ± SEM.  
 
 
 
 
Eq. 3.7 
Eq. 3.8 
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Table 3.5. Percentage of HTA at equilibrium for all 4 reactions of interest. 
Thiol and metabolite reaction, in 
HEPES pH 7.7 
Keq -  Method 1 Keq -  Method 2 
Keq % (1:1 ratio) Keq % (1:1 ratio) 
Cys (1 M) + DHAP (1 M) 8571 (±3490) 98.9% 4.8 (±0.2) 64% 
BSH (1 M) + DHAP (1 M) 12500 (±2900) 99.1% 5.9 (±0.6) 66% 
Cys (1 M) + GA3P (1 M) 18333 (±3750) 99.3% 23.9 (±2.2) 82% 
BSH (1 M) + GA3P (1 M) 17500 (±1720) 99.3% 20.9 (±0.7) 80% 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Scheme 3.4. 4 reactions of interest with each thiol reacting with DHAP and GA3P, representing the 
percentage of the equilibrium shift in the forwards and reverse reaction for both methods A) 1 – k2/k-1 
B) 2 – steady state equilibria. 
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3.5.3. Interpretation of thermodynamic equilibrium constant 
The Keq determined by the steady state equilibria (method 2) were found to be significantly 
different with a 500-2000-fold less than the Keq determined from the ratio of k2/k-1 (method 
1) (table 3.5). To explain this difference, the experiments were left for approximately 140 
minutes and 1050 minutes for thiol reacting with GA3P and DHAP, respectively, to allow 
equilibrium to be reached (figure 3.8, method 2). In this time frame, DHAP and GA3P are 
known to non-enzymatically degrade to MG, which may ultimately affect the position of the 
equilibrium. By the time the reaction has reached equilibrium, there is estimated to have 
been 10.8% degradation of GA3P whilst DHAP is estimated to have degraded by 20.8%. 
The Keq determined from the ratio of k2/k-1 (method 1) are based on the immediate kinetics 
from the rate constants and are therefore not subjected to this degradation.  
The Keq can be put into context using the quadratic equation to determine the percentage 
of reactant and product formation (chapter 6.5.2.6). With respect to method 2, the product 
formation is favoured with 64-66% and 80-82% formation of HTA for the reactivity of thiol 
with DHAP and GA3P, respectively. Whilst with respect to method 1, the product formation 
is more favoured with approximately 99% formation of HTA for the reactivity of thiol with 
DHAP and GA3P, respectively (scheme 3.4).  Both Cys and BSH showed a similar relative 
reactivity suggesting an equal thermodynamic stability of the respective HTAs.  
To conclude, all Keq were found to be >1 and HTA formation is favoured >50% in all 4 
reactions, implying a negative free energy change meaning the HTA is more stable than the 
free metabolite and thiol in solution. Therefore this may be of significance in a physiological 
setting. However, this is dependent on the intracellular concentrations of the metabolites of 
interest. 
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3.6. Physiologically relevant in vivo/ in vitro assays  
3.6.1. Intracellular concentration of metabolites in B. subtilis WT 
A second consideration for determining the importance of HTA formation is considering the 
intracellular concentration of metabolites. Table 3.6 represents the intracellular 
concentration of the glycolytic metabolites that have been measured in three different 
organisms, E. coli (Gram-negative bacteria), rat tissue (eukaryotes) and B. subtilis (BSH-
utilising Gram-positive bacteria). The concentrations were found in a variety of sources and 
therefore there will be varied results depending on the sources and experimental conditions. 
For instance, the OD600 at which the metabolite concentration was determined ranges from 
0.1-1.5. In addition, the level of carbohydrate significantly affects the concentration of 
glycolytic metabolites.(129) The metabolites which are shown to react with thiols, DHAP, 
GA3P and pyruvate are all found to range considerably in concentration from 0.07 mM(129) 
of GA3P to 145.01 mM(129) of pyruvate in B. subtilis.  However, due to the slower reactivity 
of pyruvate the focus remains on DHAP reactivity with thiol. 
All current in vivo data has been analysed using B. subtilis as the model organism grown in 
LB media. The intracellular concentration of GA3P was determined and there was no 
detectable GA3P in the cell, contrasting from the literature values which report a 
concentration of 0.07-0.12 μM(129). The DHAP concentration, however, was found to exist in 
concentrations up to 528 μM at late-exponential phase (figure 3.9A). The literature value 
produced a similar result of 540 μM at exponential phase.(129) When comparing against all 
other literature values of glycolytic metabolites, with the exception of 3-PG and pyruvate, 
the DHAP is found to be present at the highest concentration. In addition, BSH is found in 
high concentrations of approximately 3 mM at late-exponential phase.(20)  As a result, if thiol 
and DHAP are present at these concentrations and favourably equilibrate to form HTA, 
suggests that there may be significantly high intracellular pools of HTA in the cell.  
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Table 3.6. The literature values of the concentrations of glycolytic metabolites in three different 
organisms; E. coli, Rattus genus - liver tissue, and B. subtilis. 
 
Figure 3.9. A) The growth curve of B. subtilis WT. The intracellular DHAP concentrations at early, mid 
and late-exponential phase of the growth. B) The intracellular DHAP concentrations at early, mid and 
late-exponential phase of the growth normalised to an OD600 of 1. 
Metabolite 
 
E. coli 
+ Glucose  
 mM 
E. coli 
- Glucose 
 mM 
Eukaryotes 
+ Glucose  
mM 
Eukaryotes 
 -Glucose 
 mM 
B. subtilis 
+ Glucose 
mM 
B. subtilis 
- Glucose 
mM 
G-1P 1.85b(130) 0.09c(131) 4.15(130)  0.23a(129) 0.02a(129) 
F-1,6-BP 6.6b(130) 0.1c(131) 1.85(130)  0.16a(129) 0.01a(129) 
DHAP 0.37(132) 0.25b(130) 0.08(130) 0.16(133) 0.93a(129) 0.54a(129) 
GA3P 0.049(132)  2.8(130) 0.08(133) 0.12a(129) 0.07a(129) 
1,3-BPG    0.05(133) 0.1a(129) 0.07a(129) 
3-PG 1.5(132) 0.34c(131)  0.2(133) 90.46a(129) 32.34a(129) 
2-PG  0.33c(131)  0.02(133) 
PEP 0.18(132) 0.0356(134) 0.16(130) 0.065(133) 0.33a(129) 0.92a(129) 
PYV 7.5d(135) 8.658(134) 0.5(130)  8.9a(129) 145.01a(129) 
G-1P – glucose 1-phosphate, F-1,6-BP -  Fructose 1,6-Bisphosphate 
a - B. subtilis was grown in M9 minimal medium consisted of the following components (per litre): 8.5 g of Na2HPO4.2H20, 
3 g of KH2PO4, 1 g of NH4Cl, 0.5 g of NaCl. The cells were grown to an OD600 of 0.1-1.5. Malate was used in absence of 
glucose.(129) 
b - E. coli K12 was grown in minimal medium containing 30 g/L of glucose to a cell density of 10 g/L.(130) 
c -  E. coli was grown in media containing 4.7g/L KH2PO4, 13.5 g/L K2HPO4, 1 g/L K2SO4, 0.1 g/L MgSO4·7H2O, and final 
concentrations of 10 mM NH4Cl, and 4g/L of glucose to an OD600 of approximately 0.1.
(131) 
d - E.coli was grown in LB media supplemented with 20 g/L glucose 10mg/L inositol.(135) 
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3.6.2. The in vitro reactivity of DHAP with Cys and BSH, under physiologically 
relevant conditions 
The reaction between 0.5 mM DHAP with both 0.2 mM Cys and 2.5 mM BSH was analysed 
in parallel, replicating physiological cell conditions, at pH 7.7, 20 °C.  Possessing an equal 
stoichiometry of BSH to DHAP, it was speculated that approximately 0.5 mM of BSH would 
be consumed over the 200 minutes. However, more consumption is shown to take place 
due to oxidation of BSH to BSSB. The amount of oxidation taking place can be accounted 
by comparison with the controls.  
As a result, a full consumption of DHAP was found after 40 minutes of reaction with thiol, 
with approximately 0.5 mM BSH reacting (figure 3.10). BSH was 21-fold more reactive than 
Cys, with 0.04 mM of Cys reacting within 40 minutes. Approximately 0.4 mM of BSH is 
depleted within the first 10 minutes suggesting, within this period, a substantial 
concentration of DHAP could be sequestered as an HTA.  
 
 
 
 
 
 
 
 
 
 
 
Figure 3.10. Physiological conditions of BSH (2.5 mM) and Cys (0.2 mM) reactivity with DHAP (0.5 mM) 
at pH 7.7, 20 °C.   
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3.6.3. Potential physiological observations in B. subtilis  
Working on the assumption a cell could reach equilibrium between DHAP and BSH, it is 
possible to calculate the theoretical maximum HTA concentration (equation 3.9 - 3.10). As 
a result, the theoretical HTA concentration is shown to be in a large concentration, 
presenting at least twice the concentration of the free thiol/metabolite at late-exponential 
phase (figure 3.11). For example, at late-exponential phase of B. subtilis at an OD600 of 
3.55, BSH is present in 3.2 mM and DHAP is present in 0.528 mM.  If BSH and DHAP were 
in equilibrium, potentially 9.97 mM could be present as BS-DHAP HTA (figure 3.11B). 
However, in view of the complex nature of the cell with the constant production and 
metabolism of these metabolites, prevents the equilibrium of these reactions from being 
reached. This signifies that these theoretical HTA concentrations are unlikely but do 
represent the upper limits of HTA abundance. 
Table 3.7. Concentrations of reactants and theoretical concentrations of HTA. 
  Reactants  Products 
Phase OD600 BSH 
(mM)  
Cys  
(mM)  
DHAP  
(mM) 
BS-DHAP 
(mM)  
Cys-DHAP 
(mM)  
Lag  0.46 0.7(20) 0.2(20) 0.061 0.25 0.06 
Mid-exponential 1.08 1.2 0.5 0.175 1.24 0.42 
Late-exponential  3.55 3.2 0.5 0.528 9.97 1.27 
*Literature values were used for BSH and Cys concentration due to no reported data of thiol levels in the lag 
phase of growth in this research 
 
Table 3.8. Normalised data showing concentrations of reactants and theoretical concentrations of HTA 
relative to an OD600 of 1.  
  Reactants  Products 
Phase OD600 BSH/OD600 
(mM)  
Cys/OD600 
(mM)  
DHAP/ OD600 
(mM) 
BS-DHAP      
/OD600 (mM)  
Cys-DHAP   
/OD600 (mM)  
Lag  0.46 1.52(20) 0.43(20) 0.13 1.17 0.29 
Mid-exponential 1.08 1.11 0.46 0.16 1.05 0.35 
Late-exponential  3.55 0.90 0.14 0.15 0.79 0.10 
*Literature values were used for BSH and Cys concentration due to no reported data of thiol levels in the lag phase 
of growth in this research 
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Calculation of theoretical DHAP-SB HTA concentration at late-exponential phase example: 
𝐾𝑒𝑞 =
[𝐻𝑇𝐴]
[𝐷𝐻𝐴𝑃][𝐵𝑆𝐻]
 
[𝐻𝑇𝐴] = 𝐾𝑒𝑞[𝐷𝐻𝐴𝑃][𝐵𝑆𝐻] 
[𝐻𝑇𝐴] = 5.9[0.528][3.2] 
[𝐻𝑇𝐴] = 9.97 𝑚𝑀 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Eq. 3.9 
Eq. 3.10 
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A) 
 
 
 
 
 
 
 
 
 
 
 
B) 
 
 
 
 
 
 
 
 
 
 
Figure 3.11. The growth curve of B. subtilis WT and metabolite/thiol/HTA concentration. A) The 
intracellular concentrations of DHAP, Cys and theoretical Cys-DHAP HTA concentration at lag, mid and 
late-exponential phase of the growth B) The intracellular concentrations of DHAP, BSH and theoretical 
BS-DHAP HTA concentration at lag, mid and late-exponential phase of the growth. 
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Figure 3.12. The growth curve of B. subtilis WT and metabolite/thiol/HTA concentration. A) The 
intracellular concentrations of DHAP, Cys and theoretical Cys-DHAP HTA concentration at lag, mid and 
late-exponential phase of the growth, normalised to an OD600 of 1 B) The intracellular concentrations of 
DHAP, BSH and theoretical BS-DHAP HTA concentration at lag, mid and late-exponential phase of the 
growth, normalised to an OD600 of 1. 
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3.7. Significance of research and potential impact in health-related 
conditions 
There is speculation that these reactions may also exist amongst GSH-utilising eukaryotes. 
This may explain the thiol concentration changes upon high levels of glucose stress, which 
in the mammalian class of eukaryotes, is found to exist in a condition known as diabetes 
mellitus.  
Diabetes mellitus, is a chronic medical condition characterised by the recurrent high blood 
glucose levels (hyperglycaemia) which arises from defects in insulin secretion. It is known 
that prolonged hyperglycaemia contributes to the development of many vascular 
complications of the condition including nephropathy, retinopathy, and neuropathy. These 
complications arise because of the increase in oxidative stress in the cells caused by the 
high concentrations of metabolites such as MG from the increased flux of glucose 
metabolism.(136-141) In relation to thiol concentrations, serum protein GSH levels show the 
opposite effect and deplete in the tissues of diabetics.(142-145) It has been shown that there 
is a decrease in thiol levels in diabetic patients possessing a serum thiol concentration of 
605 μM relative to the control of 664 μM.(146) Whilst it is speculated that these decreased 
levels of thiol detected are partially due to the increase in oxidative stress, it becomes 
apparent that there may be a link between thiols and the carbonyl-containing 
metabolites.(147)   
The research has showed that GA3P reacts with excess GSH (400 mM).(127) However, this 
research has shown no reaction of GSH with metabolite under physiological conditions in 
eukaryotic cells; GA3P (80 μM)(133), DHAP (160 μM)(133) reacting with GSH (5 mM), pH 7.4. 
However, Cys (200 μM)(21) is known to react with DHAP and GA3P at physiological 
conditions. This has much significance amongst eukaryotes due to Cys being a fundamental 
precursor in the biosynthesis of GSH. In hyperglycaemia, an increase in metabolites would 
result in a high concentration of Cys forming the thermodynamically favoured, HTA. The 
decrease in free Cys available will significantly reduce the concentrations of GSH due to 
the decrease in its biosynthesis. In addition, this decrease in thiol will result in an overburden 
of oxidative stress in the cell, suggesting that the formation of HTA is a potentially significant 
reaction in the pathogenesis of the complications of diabetes mellitus.  
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3.8. Reactivity of other metabolites with GSH 
There is also a possibility that the LMW thiols are reacting with other reactive carbonyls to 
form HTAs. Diabetes mellitus is also known to cause an excess acetoacetic acid. It is the 
simplest beta-keto acid group and it is of biochemical importance in the breakdown of fatty 
acids into acetyl-CoA. However, in vitro analysis under physiological conditions in humans 
showed no reactivity of either Cys or GSH with acetoacetic acid. 3-Deoxyglucosone, 
malondialdehyde and 4-hydroxynonenal are all toxic dicarbonyl species which are found to 
be present in higher concentrations in diabetics. These are all toxic metabolites which have 
been known to react with the amino acid lysine causing amino acid disruption leading to 
vascular complications. There is importance in analysing the reactivity of these toxic 
carbonyl metabolites with Cys and GSH to determine whether this reaction takes place and 
the extent of the involvement of this possible reaction.  
3.9. Summary 
This research has shown that thiol cofactors including Cys and BSH chemically react with 
three glycolytic metabolites, in the order of reactivity of GA3P > DHAP > pyruvate. Both Cys 
and BSH have shown a similar rate of reactivity, with pH-independent rate constants of 
approximately 1600-fold slower reactivity than MG. Therefore, it is likely that BSH will react 
with MG preferentially over other metabolites in the cell. However, in vivo assays show that 
DHAP concentrations are shown to be in concentrations of 527.6 μM in the late-exponential 
phase. In addition, the equilibrium constants have shown that the reaction favours the 
formation of HTA when reacted with the thiol. Equal concentrations of DHAP/GA3P and 
thiol results in ~ 64 - 93% formation of HTA, with a theoretical maximum concentration of 
9.9 mM and 1.24 mM of BS-DHAP and Cys-DHAP, respectively.  
The context of these results can also relate to eukaryotes. While GSH has not shown to 
react with any metabolite under physiologically conditions, Cys does show reactivity. Cys 
forms a necessary biosynthetic intermediate of GSH. Therefore, in metabolic conditions 
such as diabetes mellitus, which is known to have increased concentration of GA3P, DHAP, 
pyruvate and MG, have unexplained reasons for low thiol levels upon hyperglycaemia. It is 
possible that the increased concentrations of metabolites are reacting with the Cys forming 
HTA. The current analytical techniques (Ellman’s reagent and MBBr reagent) have only 
shown to detect free thiol and not HTA. This may therefore explain the lower levels of thiol 
experienced in hyperglycaemia, in addition to potentially unravelling many different hidden 
thiol pools that may exist in the cell.  As such, further evidence to support the formation of 
HTA is vital in proving these reactions take place.  
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4. HTA/thiazolidine detection  
 
4.1. Overview  
Studies in the previous chapters of the reactions between thiol and carbonyl-containing 
metabolites only indirectly measured the formation of HTA. Herein, evidence to support HTA 
formation and the subsequent thiazolidine formation is presented using mass spectrometry 
and in vitro NMR analysis. Lastly, evidence of HTA existence in B. subtilis is obtained by 
whole cell NMR. 
4.2. Mass spectrometry analysis  
All six HTAs/thiazolidine derivatives were analysed on a Shimadzu ion-trap ToF mass 
spectrometer carried out by Lionel Hill (John Innes centre). The in vitro reactions of all 
samples were first carried out, allowing the potential HTAs to form. Approximately 5 mM 
thiol and 5 mM metabolite were reacted in MQ water to avoid excess levels of buffer salts 
suppressing the detection of HTA ions in the mass spectrometer. At various time points, the 
residual thiol was titrated using Ellman’s reagent to confirm sufficient HTA formation (figure 
4.1). After approximately 5 hours of reactivity between the thiol and metabolite, mass 
spectrometry analysis was carried out.  
 
 
 
 
 
 
 
 
Figure 4.1 In vitro reactivity of three metabolites with BSH/Cys in MQ water. 
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4.2.1. MG and Cys 
 
 
 
 
 
 
 
 
Figure 4.2. Spectrum of the reaction between MG and Cys, in A) region between 180-750 m/z in negative-
mode after 13 hours B) full spectrum in positive-mode after 13 hours. C) Chemical structure of 
thiazolidine derivatives.  
The mass of the Cys-MG HTA, M = C6H11NO4S, is 193.0409. The base peak is appropriate 
for an in-source dimer of the thiazolidine associated with sodium (2) [2M-2H+Na] where the 
expected mass is 371.0353 and observed mass was 371.0359, when 2M = C12H18N2O6S2. 
The identity of the other peaks remains unknown. In positive-mode, the thiazolidine 
monomer, associated with sodium (1), [M+Na] was detected, with an expected mass of 
198.0195 and observed mass of 198.0206, when M = C6H9NO3S (figure 4.2). 
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4.2.2. MG and BSH 
 
 
 
 
 
 
 
      
Figure 4.3. Full spectrum of the reaction between MG and BSH in A) negative-mode after 5 hours reaction 
time B) negative-mode after 13 hours reaction time C) Chemical structure of 1) thiazolidine derivative 2) 
HTA. 
 
The mass of the BS-MG HTA, M=C16H26N2O12S, is 470.1206. The base peak observed in 
the spectrum after 5 hours is likely to be the negative ion of the thiazolidine derivative (1) 
[M-H] with an expected mass of 451.1028 and a observed mass of 451.1042, when M = 
C16H24N2O11S. After 13 hours, the mass of the BS-MG HTA adduct (2) was observed at 
469.1162 m/z in negative mode [M-H] (figure 4.3). In the positive-mode spectrum, no mass 
for either HTA or thiazolidine was found.   
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4.2.3. DHAP and Cys 
 
 
 
 
 
 
 
Figure 4.4. Spectrum in negative-mode of the reaction between DHAP and Cys, in A) region between 
150-600 m/z. B) Chemical structure of DHAP where M= C3H7O6P is represented as, 1) [M-H] 2) [2M-H] and 
3) thiazolidine derivative [M-H] where M = C6H12NO7PS. 
 
The mass of the Cys-DHAP HTA adduct, M=C6H14NO8PS, is 291.0178. For DHAP (1) [M-
H], the expected mass is 168.9907 and the found mass was 168.9959, when M= C3H7O6P. 
The dimeric cluster ion for DHAP (2), [2M-H], was detected at 338.9899 m/z. The Cys-
DHAP HTA adduct was not detected, however, a mass consistent with the thiazolidine 
derivative (3) was detected at 272.0006 m/z, when M = C6H12NO7PS and the theoretical 
mass is 271.9999 (figure 4.4). There was no indication of HTA/thiazolidine derivative in the 
positive-mode spectrum.  
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4.2.4. DHAP and BSH 
 
 
 
 
 
 
Figure 4.5. Spectrum in negative-mode of the reaction between DHAP and BSH, in A) region between 
100-600 m/z. B) Chemical structure of 1) BSH [M-H] where M = C13H22N2O10S 2) Dephosphorylated HTA 
[M-H] where M = C16H28N2O12S. 
The mass of BS-DHAP HTA, M=C16H29N2O16PS, is 568.0975. The base peak on the 
negative-mode spectrum is BSH (1) [M-H], with an expected mass of 397.0922, which was 
detected at 397.0943 m/z, when M = C13H22N2O10S. Neither the HTA or the thiazolidine 
derivatives are detected. However, a dephosphorylated version of the HTA (2) [M-H] is 
shown indicated by a loss in H3PO4 which has an expected mass of 469.1145 and a mass 
of 469.1136 was detected, when M = C16H28N2O12S (figure 4.5). The positive-mode 
spectrum only detected masses of the protonated BSH and its sodium adduct. 
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4.2.5. GA3P and Cys 
 
 
 
 
 
 
Figure 4.6. A) Spectrum in negative-mode of the reaction between GA3P and Cys after 13 hours. B) 
Chemical structure of 1) GA3P [M-H] where M=C3H7O6P 2) Cluster ion of GA3P [2M-H] 3) Thiazolidine 
derivative [M-H] where M= C6H12NO7PS. 
 
The exact mass of Cys-GA3P HTA, M=C6H14NO8PS, is 291.0178. Since GA3P is an isomer 
of DHAP, similar peaks are observed for both. For GA3P (1) [M-H], the expected mass is 
168.9907 and the mass detected was 168.9957, when M=C3H7O6P. The base peak 
represents the cluster ion of GA3P (2) [2M-H] with an observed mass of 338.9898 . The 
HTA is not detected. However, the thiazolidine derivative (3) is detected [M-H] with a 
theoretical mass of 271.9999 and an observed mass of 272.0002, when M= C6H12NO7PS 
(figure 4.6). No masses of significance were shown on the positive-mode spectrum.  
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(4) 
4.2.6. GA3P and BSH  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.7. A) Spectrum in negative-mode of the reaction between GA3P and BSH after 13 hours B) MS2 
spectrum. C) Chemical structure of 1) BSH [M-H] where M = C13H22N2O10S 2) Dephosphorylated HTA [M-
H] where M = C16H26N2O12S 3) Thiazolidine derivative [M-H] where M = C16H27N2O15PS 4) Thiazolidine 
derivative with associated sodium [M-2H+Na]. 5) Interpretation of the fragments found on the MS2 
spectrum providing evidence of BS-GA3P HTA existence.  
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Analysis of the mass spectrum indicates a base peak for bacillithiol (1) [M-H] with an 
observed mass of 397.0941, when M = C13H22N2O10S. Similar to the BS-DHAP negative-
mode spectrum, a dephosphorylated version of BS-GA3P (2) is found with an expected 
mass of 469.1145 and a found mass of 469.1140. The BS-GA3P thiazolidine derivative (3) 
[M-H] is observed with an expected mass of 549.0797 and a mass of 549.0792, when M = 
C16H27N2O15PS. Furthermore, a sodium adduct of the thiazolidine derivative (4) [M-2H+Na], 
is detected at 571.0606 m/z. A doubly charged ion of the thiazolidine derivative [M-2H] is 
also detected with an observed mass of 274.0362. The MS2 274 data shows more evidence 
of BS-GA3P HTA existence. It appears that fragments of the BS-GA3P HTA (5) are shown 
(figure 4.7), the fumarate which is formed from β-elimination of the malate group from the 
BSH scaffold is detected with a mass of 115.0095 (5A). The glucosamine, Cys and GA3P 
fragment (5B) was detected with a mass of 433.0706, and the dephosphorylated GA3P 
(5C) was detected with a mass of 469.1153. 
4.2.7. In vitro mass spectrometric evidence of HTA or thiazolidine existence? 
The mass spectrometry data has shown strong evidence for the formation of HTAs and 
thiazolidine derivatives forming from the reaction between thiol and glycolytic metabolites. 
In each instance, there was evidence for either the thiazolidine derivative or the HTA 
adducts, and in some cases, the sodium adduct was detected. However, HTAs involving 
Cys were not detected in addition to the BS-DHAP HTA, where only a dephosphorylated 
HTA was identified (table 4.1).  
The masses mainly detected represent the thiazolidine derivative as opposed to the HTA. 
This favourability of thiazolidine detection may be possibly due to the formation in situ as 
an artefact of the mass spectrometer. In addition, the thiazolidines may fly better than the 
HTAs, allowing only trace amounts to be detected. It is also possible that the HTAs may 
not be detected due to poor stability and therefore degrading from the ionisation 
conditions of the spectrometer.  
Table 4.1. Summary of HTA/thiazolidine determination in all 6 reactions of thiol with metabolite. 
 
 
 
 
 
 Cys BSH 
 HTA thiazolidine HTA thiazolidine 
MG X ✓1 ✓ ✓ 
DHAP X ✓ ✓2 X 
GA3P X ✓ ✓3 ✓ 
1Associated sodium  
2Dephosphorylated – loss of H3PO4 
3MS2 data  
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4.3. Characterisation by Nuclear Magnetic Resonance (NMR) 
spectroscopy 
MG has shown to be the strongest electrophile relative to all glycolytic metabolites studied 
in this research. In addition, the in vivo thiol analysis has shown a reaction between 
intracellular BSH consumption when incubated with 1 mM MG. Therefore, NMR analysis 
focused on the HTA formation and/or thiazolidine formation of MG-SR. The MG-SR exists 
as two diastereomers (table 4.2), which may form additional signals and complicate the 
NMR spectra. For this reason, preliminary investigation was first carried out on the HTA 
formation between acetone and Cys, which does not result in the formation of 
diastereomers.   
Table 4.2. Two diastereomers formed from metabolite reacting with thiol. 
 S,R-diastereomer R,R-diastereomer 
MG-SR 
  
4.3.1. Acetone and Cys  
A 2:1 ratio of acetone and Cys were incubated for 3 hours. As a result, the 13C spectrum 
shows the emergence of three new peaks at δ 39.1, 66.4, 177.5, representing the CH2 (3’), 
CH (2’) and C=O (1’) of the Cys moiety of the HTA, respectively (figure 4.8). The emergence 
of each peak is at a higher chemical shift relative to the free Cys, which is possibly due to 
electron withdrawing effects of the hydroxyl group on the HTA causing deshielding.  The 
emergence of a peak at δ 75.1, confirmed by HMBC and DEPT experiment, was assigned 
to the quaternary carbon (5’) of the HTA.  
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Figure 4.8. Acetone (200 mM) reacting with Cys (100 mM) in sodium phosphate buffer (200 mM, pD 
8.1). A) Reaction scheme B) 13C spectrum. 
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To differentiate between HTA or thiazolidine, periodic 1H NMR analysis was carried out at 
20-minute intervals after incubating acetone with Cys. Signals corresponding to HTA 
emerge after 20 minutes (figure 4.9 B2), with a 1:1 ratio of Cys to HTA forming after 80 
minutes (figure 4.10). After 3 hours, two additional singlets form at δ 1.39 and δ 1.57 which 
correspond to faint carbon peaks at δ 30.6 and δ 28.5, respectively, in addition to a series 
of signals at δ 3.09-3.32 (figure 4.9 B4). These signals are speculated to be the formation 
of the thiazolidine derivative. Based on the integration, after 20 hours, the speculated 
thiazolidine was found in 1.3 mM whilst the HTA exist in 44.2 mM. 
Furthermore, the HMBC shows coupling of the quaternary carbon (5’) to protons on the CH3 
(4’, 6’) and CH2 (3’) but not the CH (2’) (figure 4.11). In the thiazolidine derivative, the proton 
on the CH (2’’) remains in close proximity within 3 bonds of the quaternary carbon whereas 
in the HTA, the proton is 4 bonds away from the quaternary carbon. Therefore, no coupling 
between the CH (2’) and the quaternary carbon is suggestive of HTA (figure 4.11).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.9. Acetone (200 mM) reacting with Cys (100 mM) in sodium phosphate buffer (200 mM, pD 8.1). 
A) Reaction scheme B) Periodic 1H NMR spectra at 1) Cys control 2) 20 mins 3) 3 hours and 4) 20 hours. 
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Figure 4.10 The consumption of Cys and the formation of HTA based on the relative ratio of Cys:HTA. 
 
 
 
 
Figure 4.11. Acetone (200 mM) reacting with Cys (100 mM) in sodium phosphate buffer (200 mM, pD 8.1). 
A) Reaction scheme. B) HMBC spectrum after 3 hours. 
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4.3.2. MG and Cys 
The formation of HTA from GSH and MG is a well-studied reaction as a result of the 
extensive research on the thiol-dependent glyoxalase detoxification pathway. NMR 
evidence of HTA formation has been proven in reactions between MG and GSH(148) (110), 
Cys(110) and CysNAc(110). However, there has been no studies of the BS-MG HTA. 
Initial studies focused on HTA formation between Cys and MG before determining the BS-
MG HTA, carried out by Dr Sunil Sharma. The NMR spectra of an equimolar mixture of Cys 
and MG showed signals corresponding to free Cys and the two Cys-MG HTA diastereomers 
after 30 minutes. The CH2 (3) for free Cys is found at δ 26.4 on the 13C spectrum. In the 
HTA form, the CH2 (3’) for both diastereomers are represented downfield at δ 37.0 and δ 
37.3, representing a similar relative chemical shift to the CH2 of the acetone-Cys HTA. The 
HSQC associates the CH2 (3’) of the HTA with four different environments on the 1H 
spectrum because of the two HTA diastereomers (figure 4.12). In relation to diastereomer 
(A), the proton signals at δ 2.62 and δ 3.23 represent the CH2 (3’) which couple to a signal 
at δ 37.3 (figure 4.12). The associated protons for the CH (2’) are found at δ 3.70 (figure 
4.13). Regarding diastereomer (B), the signals at δ 2.88 and δ 3.11 both couple to a carbon 
at δ 37.0, representing the CH2 (3’) (figure 4.12). In addition, the associated protons are at 
δ 3.89 (figure 4.13).  
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Figure 4.12. MG (10 mM) reacting with Cys (10 mM) in sodium phosphate buffer (50 mM, pD 8.1) A) 
Reaction scheme. B) HSQC spectrum showing the CH (2’) and CH2 (3’) of the Cys moiety of the two 
diastereomers (A) and (B). 
 
 
 
 
 
 
 
 
 
Figure 4.13. COSY spectrum of MG (10 mM) reacting with Cys (10 mM) in sodium phosphate buffer (50 
mM, pD 8.1), representing coupling of CH2 (3’) to CH (2’) of the Cys moiety of the two diastereomers (A) 
and (B). 
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4.3.3. MG and BSH 
The literature values of free BSH were used to assign the CH2 (3), the CH (2) and the C=O 
(1) of the Cys moiety.(8) After 30 minutes of BSH reacting with MG, the NMR spectra showed 
signals corresponding to free BSH and only one of the BS-MG HTA diastereomers. The 
signals at δ 37.6 and δ 61.4 in the 13C spectrum are suggestive of the CH2 (3’) and the CH 
(2’) for the HTA, respectively. These also resemble similar chemical shifts to the signals of 
the control adduct, Cys-MG HTA. The corresponding protons on the HSQC show CH2 (3’) 
and the CH (2’) of the HTA at δ 2.69 and δ 4.06, respectively, (figure 4.14). However, 
resonances for the CH2 (3’) of the HTA only shows one of the diastereomers. This does not 
parallel with Cys-MG HTA, where signals are observed in four chemical environments. This 
may be explained by the detection limits of the 13C spectrum.  Alternatively, the COSY 
spectrum couples the protons at δ 4.06 with δ 2.98 which may represent the CH2 (3’) of the 
other diastereomer (figure 4.15).  
 
  
Figure 4.14. MG (10 mM) reacting with BSH (10 mM) in sodium phosphate buffer (50 mM, pD 8.1). A) 
Reaction scheme. B) The HSQC showing the CH2 (3/3’) and CH (2/2’) of the Cys moiety on BSH and BS-
MG HTA. 
2’ 
3 
2 
3’ 
A) 
B) 
118 
 
  
Figure 4.15.  MG (10 mM) reacting with BSH (10 mM) in sodium phosphate buffer (50 mM, pD 8.1). A) 
Reaction scheme. B) COSY spectrum representing coupling of CH2 (3’) to CH (2’) of the Cys moiety of 
only one diastereomer. 
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4.4. Whole cell NMR 
Whole cell NMR was then carried out to provide direct evidence of BSH and HTA existing 
in the cell. This idea was prompted by recent studies of whole cell NMR which had been 
carried out on mammalian cells incubated with 13C-labelled GSH (GSH-(glycine-13C2,15N) to 
measure GSH and its disulfide in the cell.(149) On parallel lines, it was predicted that 
incubating B. subtilis with media supplemented with 13C-Cys, would be taken up into the cell 
and biosynthesise into BSH. Cys, however, is not specific for the biosynthesis of BSH and 
there are other compounds, such as cystathionine, homocysteine, S-adenosylmethanione, 
CysNAc, CoA, acetyl-CoA, and L-methionine, which may be detected.(150) Nonetheless, 
BSH remains in high concentrations in late-exponential phase of B. subtilis and therefore it 
is anticipated that there will be detectable amounts of BSH and potential HTA in the cell.  
4.4.1. In vivo formation of BSH 
The experiments were carried out by Francesc Puig. B. subtilis WT and glxI mutant cell 
cultures were inoculated with 13C-labelled Cys (1 mM) in the lag-phase. Cys rapidly oxidised 
to cystine in the culture,(151) which was confirmed by Ellmans titration after 2 hours, showing 
50% oxidation at 37 °C, 200 RPM. However, this oxidation is favourable as B. subtilis cells 
can only uptake cystine.(151) At time-points of growth, the cultures were centrifuged and cell 
pellets were analysed under NMR. BSH was detected at 1H = δ 3.03, 3.10 and 13C = δ 28.2 
(figure 4.16). The in vitro analysis confirms this, which shows BSH at 1H = δ 3.05, 13C = δ 
28.1, representing the CH2 (3) of BSH. There was no observable BSSB, which is explained 
by the low concentrations found in the cell relative to BSH, with a redox ratio ranging from 
100:1 to 400:1, BSH:BSSB.(20) In addition, there is no observable Cys, which is possibly 
explained by being approximately 15-fold less concentrated than BSH at the late-
exponential phase, and therefore below the detection limits of NMR.  
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Figure 4.16. A) Chemical structures of BSH and BSSB. B) In vitro HSQC NMR, representing CH2 (3) of 
BSH (black) and BSSB (red). C) In vivo HSQC NMR, representing the CH2 of BSH.  
CH2 of BSH 
CH2 of BSSB 
(B) 
 
(A) 
 
(C) 
 
CH2 of BSH 
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4.4.2. In vivo formation of BS-MG HTA 
In a separate experiment, the WT and glxI mutant cellular cultures were individually 
inoculated with 1 mM of MG for 30 minutes, the cell pellets were centrifuged and analysed 
under NMR. In relation to the WT strain, the signals representing the CH2 (3) are at 1H = δ 
3.015, 3.095 and 13C = δ 27.7, representing BSH. Upon addition of MG, the resonance 
remains, suggesting no reaction of BSH. This does not replicate the observations from the 
in vivo studies (chapter 2.5.2). A plausible reason for this is the time consuming nature of 
the NMR analysis allowed sufficient time for the BSH to react with MG to form HTA which 
then subsequently follow through the glyoxalase pathway and hence recover.  
The glxI mutant prevents BSH from following through the glyoxalase pathway and therefore 
it is only in equilibrium with HTA. As a result, there was evidence of HTA formation. Firstly, 
the weak resonance of the CH2 (3) of BSH indicates that it has reacted with MG (figure 
4.17). In addition, four weak signals emerge, at 1H = δ 2.72 and 13C = δ 39.6, 1H = δ 3.32 
and 13C = δ 40.0, 1H = δ 3.21 and 13C = δ 40.2 and 1H = δ 2.96 and 13C = δ 40.0. Whilst the 
in vitro NMR of BS-MG only identified one diastereomer, the signals emerging herein closely 
resemble the in vitro Cys-MG HTA (chapter 4.3.2 - figure 4.12). Since Cys is speculated to 
be below the detection limits of this analysis, it is plausible it could be BS-MG. However, 
further investigation would require a repeat of the in vitro BS-MG HTA NMR analysis to 
confirm these observations.  
 
 
 
 
 
 
 
 
 
 
Figure 4.17. Whole cell HSQC NMR of 13C-labelled Cys incubated GlxI mutant strain. A) Reaction scheme 
of MG and BSH reaction. B) The CH2 of BSH with no addition of MG. C) Resonance of speculated CH2 of 
BS-MG after the addition of 1 mM MG. 
(A) 
 
CH2 of BS-MG  
CH2 of BSH (B) 
 
(B) 
 
(C) 
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4.5. Summary 
The mass spectrometry data analysis shows the favoured formation of thiazolidines as 
opposed to the HTA adduct. This contrasts from the in vitro NMR data which show HTA 
formation between acetone and Cys with only traces of thiazolidine being detectable. In 
addition, the similar relative chemical shifts of the CH and the CH2 group of Cys-acetone, 
Cys-MG and BS-MG are suggestive that an HTA adduct is formed. The whole cell NMR 
provided in vivo evidence of HTA formation between BSH and MG. Whilst the WT strain 
showed no effect of BSH from MG, the glxI mutant strain showed some depletion of BSH 
and additional weak resonance, but the signals observed paralleled with the in vitro NMR 
spectra indicating possibly HTA formation.   
The limitations of the NMR analysis were the weak signals observed for all the in vitro MG-
SB spectra, only detecting one of the diastereomers. Therefore, future work should 
implement a higher BSH concentration which would produce a more accurate comparable 
measure for the whole cell NMR. There are many other metabolites that have shown to 
react with BSH, including DHAP which is shown to possess a high theoretical DHAP-SB 
concentration, however, due to time constraints were not investigated. Therefore, further 
investigation would involve determining the in vivo NMR existence of these glycolytic 
metabolites and BSH.  
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5. Conclusion  
 
In summary, this research has shown clear evidence of the involvement of BSH in the thiol-
dependent glyoxalase detoxification of MG. The in vitro kinetics have shown a similar rate 
of Cys and BSH thiolate reactivity with MG, producing comparable pH-independent rate 
constants of 9.46 and 7.55 s-1, respectively. However, the thiol pKa of BSH is lower than 
Cys which indicates that it is more deprotonated at physiological conditions, pH 7.7, in B. 
subtilis, resulting in a faster rate of reaction with MG. Moreover, the intracellular 
concentration of BSH is 15-fold higher than Cys at late-exponential phase, further 
suggesting the preferential reactivity with BSH.   
One limitation of the in vitro kinetic studies was that they could not be determined at 
physiological cell conditions due to a full consumption of thiol occurring within seconds. 
Therefore, for further investigation, alternative techniques using stopped-flow assays for 
determination of the immediate kinetics could be implemented. This would provide a rate 
constant at pH 7.7 which is necessary for the determination of the equilibrium constant. In 
addition, another key aspect of the kinetic analysis is the potential reactivity of the amino 
group on Cys and BSH, which may react with MG to form a Schiff base. Therefore, further 
investigation using ninhydrin reagent(152) in determining the reactivity of the amino group is 
essential for the full analysis of BSH reactivity.  
The in vivo studies, confirmed the kinetic observations which showed BSH levels to rapidly 
deplete upon exposure to 1 mM MG amongst B. subtilis cells. The BSH levels then gradually 
recover in the WT and glxI mutant, however BSH remains depleted in the glxII mutant. In 
parallel, there is extracellular consumption of MG in all strains which is indicative of the 
uptake of the metabolite into the cells and subsequent detoxification. Thus, providing strong 
evidence of chemical reactivity of BSH with MG, and its involvement in the glyoxalase 
system as a mechanism of MG detoxification, with BSH being the dominant thiol in the 
process.   
In view of the strong nucleophilicity of BSH through its chemical reactivity with MG, there 
remained much interest in exploring the possible reactivity with other carbonyl-containing 
metabolites in glycolysis. DHAP, GA3P and pyruvate were all shown to react with Cys and 
BSH, with the most reactive being GA3P > DHAP > pyruvate. The rate constants were 
approximately 1600-fold slower than thiol reactivity with MG. However, the intracellular 
concentrations of DHAP were shown to exist in relatively high levels of approximately 0.5 
mM at late-exponential phase of B. subtilis growth. Therefore, using the equilibrium 
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constants, a maximum theoretical HTA concentration was speculated to exist up to 1.27 
and 9.97 mM of Cys-DHAP and BS-DHAP HTA, respectively. This is suggestive that the 
HTA has potential to form in vast concentrations in the cell.  
Since these potentially high concentrations of HTA may form in the cell, it remained 
essential to provide direct evidence these molecules exist. Evidence suggesting RS-MG, 
RS-GA3P and RS-DHAP HTA formation were found using mass spectrometry. The masses 
predominantly detected were the thiazolidine as opposed to the HTA, which contrasted from 
the NMR data with the HTA being predominant in all the reactions. Furthermore, whole cell 
NMR provided indication of HTA formation of the MG-SR. It showed some depletion of BSH 
and potential HTA formation upon external MG incubation (table 5.1). However, further in 
vitro NMR analysis of BS-MG are required to confirm this data due to weak signals shown 
on the 13C NMR spectrum. 
In view of the time constraints of this research, further in vivo work to confirm the 
thermodynamic observations of HTA favourability from BSH reacting with DHAP, would be 
essential. Therefore, whole cell NMR analysis could be implemented. However, the BS-MG 
has shown to be on the threshold of the detection limits from the weak resonances 
observed. Thus, alternative techniques such as mass spectrometry on cell lysates, may 
prove effective for determining this intracellular reaction due to the higher sensitivity. 
However, this may be technically quite challenging. 
Table 5.1 Mass spectrometry, in vitro NMR and whole cell NMR data confirmation of product formation 
from thiol and metabolite reactivity.  
 
 
 
 
 
 
 
 
 
 
 Thiol MG DHAP GA3P 
Mass 
spectrometry 
Cys thiazolidine1 thiazolidine thiazolidine 
BSH HTA  
thiazolidine 
HTA2 HTA3 
thiazolidine 
In vitro NMR Cys HTA Further 
investigation 
- 
BSH HTA Further 
investigation 
- 
Whole cell 
NMR 
Cys No formation Further 
investigation 
- 
BSH Possible HTA  Further 
investigation 
 
1Associated sodium  
2Dephosphorylated – loss of H3PO4 
3MS2 data 
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In general, this research relates to a wide range of different settings, from the growth of 
bacteria in carbohydrate-rich conditions, to yeast undergoing fermentation, or even the high 
blood sugar levels observed in diabetes. These are all examples of fluctuating levels of 
glycolytic metabolites in the cell and when present in high concentrations may result in a 
significant HTA concentration. This research therefore helps provide more of an insight into 
the functioning of cellular processes. For example, low concentrations of thiol are detected 
amongst hyperglycaemia in diabetics. (142-145) It has often just been assumed that this is due 
to an increase in oxidative stress resulting in a decrease in free thiol. However, this research 
has explored the idea of alternative observations, in that a glucose overload would result in 
more thiol sequestered as HTA. In addition, the fact that generic analytical techniques, such 
as mBBr do not detect HTA is suggestive that the true total thiol content in the cell exists in 
significantly higher concentration than previously thought.  
In conclusion, the outcomes of this research have shown that potentially significant 
concentrations of thiol are being sequestered as HTA, which may be present when thiols 
react with the many reactive carbonyl-containing metabolites in the cell, all contributing to 
this  ‘unknown thiol reservoir.’  
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6. Materials and Methods 
 
6.1. Materials and suppliers  
Unless otherwise stated, all chemicals were obtained from Sigma-Aldrich, Fisher Scientific, 
VWR-BDH and Alfa-aesar. Glycolytic metabolites were purchased from Sigma-Aldrich at 
their highest purity. Methylglyoxal was obtained as a 40% solution and purified as described 
herein. All enzymes were purchased from Sigma-Aldrich.  
6.2. Equipment specification 
6.2.1. UV-vis spectrophotometer  
Ultraviolet-visible (UV-vis) absorbance measurements were carried out on a PerkinElmer 
UV Lambda 25. Quartz cuvettes were used when measuring a full wavelength absorbance 
from 200 nm-800 nm whilst polystyrene cuvettes were used when measuring an 
absorbance above 340 nm. An Ultrospec 10 cell density meter was used for the 
determination of the Optical Density (OD600) for the bacterial growth curves. 
6.2.2. High Performance Liquid Chromatography 
High Performance Liquid Chromatography (HPLC) analysis was carried out on Jasco HPLC 
system comprising of two Jasco PU 1580 pumps, a MX-2080-32 dynamic mixer, a DG-
1580-53 3-line degasser, a JASCO AS-2055 auto-injector and a JASCO FP-2020 
fluorescence detector. Milli-Q water and HPLC-grade solvents were used for all HPLC 
analysis.  
Thiol-mB peaks were separated by HPLC on a Kinetex 2.6u C18 100A column measuring 
at 100 x 4.6 mm. Analysis was performed at 38 °C with 95% Solvent A (0.25% v/v acetic 
acid and 10% methanol, adjusted to pH 4 with NaOH) and 5% Solvent B (90% methanol). 
A gradient profile was carried out; 0 – 2 min; 5% solvent B, 2 – 8 min; 5 – 32 % solvent B, 
8 – 10 min; 32 – 100% solvent B, 10 – 11 min; 100 – 5 % solvent B, 11 – 16 min; 5 % 
solvent B.  Each pump was set to a flow rate of 1.5 mL/min. Detection was carried out using 
a Jasco fluorescence detector with excitation at 385 nm and emission at 460 nm, and a gain 
of 1x. Standard retentions times for BSmB and CysmB were 4.3 and 4.7 mins respectively.  
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6.2.3. Nuclear Magnetic Resonance spectrometer 
1H and 13C Nuclear Magnetic Resonance (NMR) spectra were obtained on a Bruker 400 
MHz and Bruker S500 MHz Spectrometer.  Chemical shifts for 1H and 13C NMR are quoted 
in parts per million (δ) and coupling constants (J) are quoted in hertz (Hz). The abbreviations 
are used; s = singlet, d = doublet, t = triplet, dd = doublet of doublets, m = multiplet. 
6.2.4. Mass spectrometer 
Liquid chromatography - Mass spectrometry (LC-MS) analysis was carried out on a 
Shimadzu ion-trap Time-of-flight (IT-ToF) mass spectrometer using a Prominence/Nexera 
UHPLC system to introduce the samples.  
6.2.5. pH meter 
pH measurements were made on a SUNTEX microprocessor pH meter SP-2200. The pH 
probe was calibrated with standard buffers, pH 7 for basic measurements and pH 4 for 
acidic measurements.  
6.2.6. Autoclave and laminar airflow cabinet 
All growth media including Lysogeny Broth (LB), Belitsky minimal (BM) media, LB agar, 
equipment and apparatus unless otherwise stated were sterilised by autoclaving using 
Systec DB-100. All cell culture work was carried out in a sterile class II Laminar airflow 
safety cabinet.  
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6.3. Preparation of LMW thiols, MG and glycolytic metabolites 
6.3.1. Preparation and storage of metabolites, cofactors and enzymes 
All thiols, glycolytic metabolites and MG were stored at -30 °C. DHAP and GA3P were 
aliquoted into 1 M, 100 mM, 50 mM and 10 mM stocks. Purified MG was aliquoted into 425 
mM, 100 mM, 50 mM and 10 mM. In each instance, a fresh stock was used on a daily basis 
due to poor stability.(71) Enzymes were aliquoted into eppendorf’s containing 50 units each. 
Due to their susceptibility of denaturing, glycerol 3-phosphate dehydrogenase was prepared 
in 50 mM HEPES buffer, pH 7.7 and glyceraldehyde-3 phosphate dehydrogenase was 
prepared in 50 mM triethanolamine, pH 8. All thiols including Cys and GSH were 
commercially available apart from BSH, which was previously synthesised by Dr Sunil 
Sharma.(8)  
6.3.2. Preparation of pure methylglyoxal  
Commercially available MG (40% solution) presented in an impure form consisting of MG 
and pyruvaldehyde dimethyl acetal. Pure stocks of MG were therefore prepared, by Dr Sunil 
Sharma, from pyruvaldehyde dimethyl acetal as described below.(112) 
Dowex-X8 resin (H+-form, 2.5 g) was washed with water and treated with 1 M HCl for 2 
hours. The resin was filtered and washed with water until reaching a neutral pH followed by 
methanol (30 mL) and DCM (30 mL). In a two neck round bottom flask fitted with a Vigurex 
condenser, a mixture of pyruvaldehyde dimethyl acetal (10 mL), Dowex-X8 (H+-form, 2.4 g) 
in MQ water (150 mL) was heated at 95 °C under a nitrogen atmosphere for 90 min and left 
overnight at room temperature (scheme 6.1). An aliquot of 450 µL reaction mixture was 
mixed with 50 µL D2O for NMR analysis to monitor the progress of the reaction and 
determine purity of the product. 50 mL water was added and the mixture was concentrated 
to a volume of ~120 mL under vacuum. This was repeated five times to remove remaining 
starting material and methanol. Finally, the Dowex resin was removed by filtration. The 
concentration of MG was determined by quantitative 1H NMR (425 mM, >98% purity). The 
solution was stored at -30 °C.  
 
 
 
 
Scheme 6.1. The acid hydrolysis of pyruvaldehyde dimethyl acetal to purify MG solution (>98% purity). 
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6.4. Analytical methods  
6.4.1. Thiol quantification by titration with Ellman’s reagent – 5,5- dinitrothiobis-(2-
nitrobenzoic acid) (DTNB)(153) 
Thiol quantification was determined using Ellman’s reagent – 5,5-dinitrothiobis-(2-
nitrobenzoic acid) (DTNB). The thiol reacts with DTNB cleaving the disulfide bond in a 
nucleophilic substitution to produce 2-nitro-5-thiobenzoate (TNB-) which ionises to the TNB2- 
at pH 7.4 producing a yellow colour (scheme 6.2). A rapid reaction takes place which is 
stoichiometric, meaning the addition of one mole of thiol produces one mole of TNB2-. The 
TNB2- is measured at 412 nm on the UV spectrophotometer and quantified using the 
extinction coefficient of DTNB being 14150 M-1cm-1.(154) Using Beer-Lambert law, where A 
is absorbance, ε is the extinction coefficient (M-1 cm-1), c is concentration (M) and l is path 
length (cm), the concentration of thiol was determined.  
 
 
 
Scheme 6.2. Thiol quantification showing a thiol-disulfide exchange reaction between DTNB and 
reactive thiolate.  
 
 
 
 
 
 
 
 
 
ε412 = 14150 M-1 cm-1 
130 
 
6.4.2. MG quantification by titration with Brady’s reagent - 2,4-
dinitrophenylhydrazine (2,4-DNPH) 
MG concentration was measured using Brady’s reagent. It is used qualitatively to detect 
carbonyl groups of ketone and aldehyde functional groups.(155) 2,4-DNPH reacts with MG 
to form a hydrazone (scheme 6.3).(121) (122) The hydrazone forms a yellow/orange colour 
which produces an absorbance at 432 nm on the UV spectrophotometer. Standardisation 
curves were produced ranging from 0 μM to 125 μM which were used as the comparable 
measure to determine the MG concentration.  
 
 
 
 
 
 
Scheme 6.3. 2,4-Dinitrophenylhydrazine (2,4-DNPH) reacts with MG to form 2,4-dinitrphenylhydrazone 
which is UV-active at 432 nm.  
6.4.3. Thiol quantification using monobromobimane (mBBr) 
Monobromobimane (mBBr) is a thiol labelling reagent used to quantify LMW thiols. The 
weakly fluorescent compound selectively reacts with thiols in a nucleophilic substitution 
reaction to produce a highly fluorescent and stable thioester (mB-SR) allowing detection on 
HPLC (scheme 6.4).(120) This technique can be used to detect all LMW thiols at picomolar 
concentrations for both in vitro and cellular samples. Cellular thiol concentration is 
expressed as μmol/g of residual dry weight (RDW). 
 
Scheme 6.4. Thiol quantification representing a reaction of the thiolate with mBBr to produce a 
fluorescent thioester which can be detected on HPLC.  
 
λ = 432nm 
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6.4.4. DHAP quantification using the glycerol 3-phosphate dehydrogenase assay 
The concentration of DHAP was determined by measuring the oxidation of NADH to NAD+ 
to produce glycerol 3-phosphate (G3P) (scheme 6.5). The reaction was catalysed by 
glycerol 3-phosphate dehydrogenase (G3PD) enzyme and monitored NADH consumption 
to NAD+ at 340nm on the UV-vis spectrophotometer. The extinction coefficient of NADH is 
found to be 6.22 × 103 M-1 cm-1 expressed in μmol of NADH produced per min per mg of 
protein.(156) 
 
 
 
 
 
Scheme 6.5. Quantification of DHAP analysing the reduction of DHAP to G3P, catalysed by G3PD. 
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6.4.5. GA3P quantification using the glyceraldehyde 3-phosphate dehydrogenase 
assay 
The concentration of GA3P was determined by measuring the formation of NADH from 
NAD+ to form 3-phospho-D-glycerate catalysed by glyceraldehyde 3-phosphate 
dehydrogenase (GA3PD). The reaction was catalysed by the GA3PD enzyme and 
monitored at 340 nm on the UV-vis spectrophotometer. Free phosphate was required to 
form 1,3-bisphospho-D-glycerate however it was found that this reaction was reversible 
(scheme 6.6). Therefore, arsenate was used, irreversibly forming 3-phospho-D-glycerate 
(scheme 6.7). The extinction coefficient of NADH is found to be 6.22 × 103 M-1 cm-1.(156) 
 
Scheme 6.6. Ineffective quantification of GA3P analysing the oxidation of D-GA3P to 1,3-BPG in sodium 
phosphate buffer catalysed by GA3PD. 
 
Scheme 6.7.  Effective quantification of GA3P analysing the oxidation of D-GA3P to 1-arseno-3-phospho-
D-glycerate. The use of arsenate forms the unstable 1-arseno-3-phospho-D-glycerate, which irreversibly 
breaks down to form 3-phospho-D-glycerate.  
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6.5 In vitro experiments 
6.5.1. MG assays  
6.5.1.1 Thiol quantification 
Thiols were quantified by the absorbance measured (412 nm) on the UV-vis spectrometer 
upon reaction with 2 mM 5,5-dinitrothiobis (DTNB) in 50 mM HEPES (chapter 6.4.3). The 
extinction coefficient of DTNB is 14150 M-1cm-1.(153) 
6.5.1.2. Relative rate of Cys/BSH reactivity with MG assay 
MG (1500 μM) was reacted with Cys/BSH in sodium phosphate buffer pH 5.6 at 20 °C. 
Ellman’s titration(153) (chapter 6.4.3) was carried out at 10-second and 1-second time points 
for Cys and BSH, respectively, under pseudo-first order reaction kinetics. Due to the higher 
concentrations of GSH/CysNAc required for reactivity, MG (5 mM) was reacted with GSH 
and CysNAc in a sodium phosphate buffer pH 7.7, 20 °C. Ellman’s titration(153)  was carried 
out at minute intervals over the first 5 minutes and then every 5 minutes, thereafter. Different 
initial concentrations of thiol were analysed to allow comparable thiolate reactivity (table 
6.1). For example, at pH 5.6, 63 μM BSH and 200 μM Cys correspond to 0.2932 μM thiolate. 
Table 6.1. Assay conditions for the reactivity of all 4 thiols with excess MG (1500 μM)   in pseudo-first 
order conditions, allowing relative rate of reactivity at comparable thiolate concentrations.  
Thiol 
cofactor 
Thiol 
concentration 
(μM) 
Thiolate 
concentration 
(μM) 
MG 
concentration 
(μM) 
pH Time 
intervals (s) 
Temp 
 
(°C) 
Cys 70/200 0.1026/0.2932  1500 5.6 10  20 
BSH 63 0.2932 1500 5.6 1  20 
GSH 2100 61 5000 7.7 60 20 
CysNAc 4200 61 5000 7.7 60 20  
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6.5.1.3. Determination of the forwards and reverse rate constants 
For determination of the forwards rate constant, Ellman’s titration was used to determine 
thiol consumptions over a range of initial thiol concentrations (100 μM – 2000 μM) when 
incubated with MG (1500 μM), in sodium phosphate buffer pH 5.6, 20 °C. 
Likewise, Ellman’s reagent was used for the determination of the reverse rate constant. 
Thiol (5 mM) and MG (10 mM) was initially reacted in HEPES pH 7.7 until there was a full 
consumption of thiol, confirmed by Ellman’s reagent, implying that the HTA has formed 
(scheme 6.8A).  Several dilutions of the newly formed HTA (125 - 750 μM) were then 
individually quenched with Ellman’s reagent, pH 7.7. The Ellman’s reagent labels the 
residual thiol resulting in a shift in equilibrium allowing the dissociation of HTA to be 
determined (scheme 6.8B). An increase in absorbance represents thiol being liberated as 
the HTA dissociates back to form thiol and MG  
 
Scheme 6.8.  A) The reaction of thiolate and MG to form HTA. B) DTNB reacting with residual thiolate 
therefore altering the equilibrium allowing determination of the off-rate of reaction.  
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6.5.1.4. Reactivity of thiol and MG >5 hours 
Cys and BSH were incubated with different concentrations of MG at 37 °C where the 
reactivity was analysed over a longer period than previously investigated, (>6 hours). 2 mM 
Cys/BSH and 2 mM/10 mM MG were assayed in 1:1 and 1:5 ratio in sodium phosphate 
buffer, pH 7.4, for 6 hours.(110) The thiol groups were assayed at the appropriate time points 
using Ellman’s reagent as previously described (chapter 6.4.3, 6.5.1.1).(153) 
Due to the length of the reaction, a possible decrease in free thiol content could be the result 
of an oxidation process. Controls of thiol in sodium phosphate buffer were carried out where 
there was found to be 4% and 10% total thiol oxidation in Cys and BSH over the course of 
the experiment, respectively.  
6.5.2. DHAP/GA3P assays  
6.5.2.1. DHAP quantification using the G3P dehydrogenase assay 
The concentration of DHAP was determined by measuring the conversion of NADH to 
NAD+ to produce glycerol 3-phosphate catalysed by glycerol 3-phosphate dehydrogenase. 
B. subtilis physiological cell conditions were adopted using HEPES buffer pH 7.7, 25 °C. 
The reaction mixture contained 134 mM HEPES and 0.1 mM DHAP. The addition of 0.13 
mM NADH corresponded to ~ 0.7 A. The reaction was initiated by the addition of 1U of 
G3PD enzyme and NADH consumption to NAD+ was monitored at 340 nm for 5 minutes 
on the UV-vis spectrophotometer. Enzyme activity of 1 U is defined as the amount of 
enzyme producing 1 μmol product / min at 25 °C. (157)   The extinction coefficient of NADH is 
found to be 6.22 × 103 M-1 cm-1 and using Beer-Lambert law, the concentration was 
found.(156) 
6.5.2.2. Determining GA3P concentration using the GA3PD assay 
The concentration of GA3P was determined by measuring the formation of NADH from 
NAD+ to form 3-phospho-D-glycerate catalysed by glyceraldehyde 3-phosphate 
dehydrogenase (GA3PD). This assay was carried out in a reaction mixture containing 100 
mM triethanolamine (TEA),(158) pH 8, 1 mM NAD+, 10 mM sodium arsenate and 0.1 mM 
GA3P. The reaction was started by the addition of 1U of GA3PD enzyme and monitored at 
340 nm for 15 minutes on the UV-vis spectrophotometer. The enzyme only catalyses the 
reaction of one of the enantiomers in the racemic mixture. 
 
 
 
136 
 
6.5.2.3. Triethanolamine/tris/phosphate buffer use in GA3PD assay 
The literature has been shown to use many different types of buffer to regulate the pH of 
this assay.(159, 160) However, the use of different buffers results in a varied final absorbance. 
Originally, Tris(161) pH 8 was used as the buffer of choice, however it was found to produce 
an unexpectedly low absorbance after carrying out the assay. A plausible reason for this is 
due to the reactive nature of the primary amine in the Tris buffer which is possibly 
undergoing a nucleophilic substitution with the arsenate-containing metabolite. TEA 
contains a tertiary nitrogen making it less likely to react with carbonyl functional groups.  
6.5.2.4. Importance of arsenate in the GA3PD assay 
Originally phosphate buffer/tris buffer (supplemented with phosphate) was used with the 
idea that the free phosphate from the buffer would act as the source for the formation of 
1,3-bisphospho-D-glycerate.(159) However, it was found that this reaction is reversible and 
therefore it doesn’t quantify all the GA3P in solution. The use of arsenate resulted in a higher 
absorbance representing the higher expected concentration of GA3P. It was found that the 
addition of arsenate results in the production of arseno-3 phospho-D-glycerate which then 
irreversibly decomposes to form 3-phospho-D-glycerate (scheme 6.9).(157) Control assays 
show a quantification of 4.21 mM GA3P in the presence of arsenate as opposed to 3.70 
mM GA3P in the absence showing a fairly significant difference in concentration (>10%).  
 
Scheme 6.9. Q132uantification of GA3P analysing the oxidation of D-GA3P to 1-arseno-3-phospho-D-
glycerate. The use of arsenate forms the unstable 1-arseno-3-phospho-D-glycerate, which irreversibly 
breaks down to form 3-phospho-D-glycerate.  
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6.5.2.5. Determination of equilibrium constants (Keq) 
Stock solutions of DHAP, GA3P and thiols were quantified using GPD assay, GA3PD assay 
and Ellman’s titration, respectively. Assays were developed consisting of 5 different 
concentrations of thiol to metabolite ratios including 1:1, 5:4, 3:2, 7:4, 2:1, (RSH:C=O). The 
specific reaction was left to equilibrate in HEPES (50 mM) pH 7.7.  
For determination of the equilibrium constant for DHAP and thiol, the thiol was first titrated 
using Ellman’s reagent to determine the initial concentration of thiol before reacting with 
DHAP until equilibrium had been reached. The reaction was carried out in an inert 
atmosphere in a glove box to prevent any possible oxidation of the thiols. After 16 hours, 
the thiols were quantified and this was repeated on an hourly basis to confirm whether 
equilibrium had been reached. The residual DHAP concentration was then determined 
using the GPD assay.  
For determination of the equilibrium constant for GA3P and thiol, similarly the thiol was 
titrated using Ellman’s reagent to determine the initial concentration of thiol. However, it is 
known that the reaction between GA3P and thiol takes place at a faster rate than DHAP. 
After 3 hours, the thiols were quantified and this was repeated on 30-minute basis to confirm 
whether equilibrium had been reached. The residual GA3P concentration was then 
determined using the GA3PD assay. The equilibrium constant (Keq) was calculated (Eq. 1 - 
chapter 6.5.2.6). 
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6.5.2.6. The use of the quadratic equation to determine HTA Keq as a percentage 
An alternative way of expressing the Keq is representing the equilibrium as a percentage. 
This was achieved by using simultaneous equations (equation 6.2) and the quadratic 
equation (equation 6.7). 1 M DHAP/GA3P and 1 M BSH/Cys were used in the examples to 
determine the concentration dependent percentage of HTA formation at equilibrium (table 
6.2).  
Table 6.2. Calculations to determine algebraic equations to determine percentage of HTA at 
equilibrium.   
 
 
𝐾𝑒𝑞 =
[𝐻𝑇𝐴]
[𝐶 = 𝑂][𝑅𝑆𝐻]
 
10 =
[𝑥]
[(1 − 𝑥)(1 − 𝑥)]
 
𝐾𝑒𝑞[(1 − 𝑥)(1 − 𝑥)] = [𝑥] 
10 (𝑥2 − 2 𝑥 + 1) = 𝑥 
10 𝑥2 −  20 𝑥 + 10 = 𝑥 
10 𝑥2 − 21 𝑥 + 10 =  0 
𝑥 =
−𝑏 ± √𝑏2 − 4𝑎𝑐
2𝑎
 
𝑥 =
21 ± √(2 − 4 x 10 x 10
2 x 10
 
𝑥 = 0.73 = 73 % 
 
 Thiol (M) DHAP/GA3P (M) HTA (M) 
BSH/Cys and DHAP/GA3P reaction 
Initial concentration 1 M 1 M 0 M 
Change in concentration -x  -x +x 
Concentration at equilibrium  1 - x 1 - x x 
Eq. 6.1 
Eq. 6.2 
Eq. 6.3 
Eq. 6.4 
Eq. 6.5 
Eq. 6.6 
Eq. 6.7 
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6.5.2.7. Oxidation of thiols in the determination of equilibrium constants (Keq)  
The assays carried out to determine the equilibrium constants (Keq) were carried out over 
long period of time therefore the thiols are more susceptible to oxidation forming disulfide 
bonds. It was found that BSH oxidises more rapidly than Cys, with GSH being the most 
stable. Many different measures had been undertaken to prevent this oxidation including 
the maintenance of an anaerobic environment using nitrogen gas from the tap and nitrogen-
infused balloons. However, the only proven technique that greatly reduces levels of 
oxidation was the use of nitrogen chamber where approximately 10% and 3% oxidation was 
determined in BSH and Cys after 12 hours, respectively.  
6.5.2.8. Determination of the forwards and dissociation rate constants 
For determination of the forwards constant, Ellman’s titration was used to determine thiol 
consumptions over a range of initial thiol concentrations (>5) ranging from 200 μM – 1600 
μM. The thiol was incubated with 10 mM DHAP/GA3P in 50 mM HEPES buffer, pH 7.7, 20 
°C. Ellman’s titration was carried out every 60 seconds to determine the concentration of 
residual thiol.  In terms of the reverse rate constant, Ellman’s reagent was used to quantify 
the formation of thiol from DHAP-SR HTA and GA3P-SR HTA The assay was carried out 
using the same method for the reverse rate constant for MG-SR HTA (chapter 6.5.1.3).  
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6.5.3 In vitro HPLC assays 
6.5.3.1. In vitro kinetics of BSH and Cys reactivity with DHAP under physiological 
conditions    
The reaction between DHAP with both BSH and Cys was assessed under physiological 
conditions. 3 mM BSH and 0.2 mM Cys were reacted with 0.528 mM DHAP in a sodium 
phosphate buffer, pH 7.7 at 20 °C. HPLC thiol analysis was required to quantify both thiols 
in parallel. MBBr derivatisation was carried out at time points = 0, 2, 5, 10, 20, 30, 60, 180 
minutes. This process involved reacting 5 μL of bimane mix (50% acetonitrile containing 2 
mM mBBr and 20 mM HEPES pH 8.0) with 5 μL sample. These samples were incubated at 
60 °C for 10 min in the dark, and then cooled on ice. The samples were acidified by the 
addition of 5 M methanesulfonic acid, and a further 1 in 5 dilution in 10 mM methanesulfonic 
acid. HPLC was performed at 38 °C with 95% Solvent A (0.25% v/v acetic acid and 10% 
methanol, adjusted to pH 4 with NaOH) and 5% Solvent B (90% methanol). Samples were 
eluted with a gradient of Solvent B with a 1.5 mL/min as follows: 0 – 2 min; 5% solvent B, 2 
– 8 min; 5 – 32 % solvent B, 8 – 10 min; 32 – 100% solvent B, 10 – 11 min; 100 – 5 % 
solvent B, 11 – 16 min; 5 % solvent B. Detection was carried out with a Jasco fluorescence 
detector with excitation at 385 nm and emission at 460 nm, and a gain of 1x. Standard 
retentions times for BSmB and CysmB are 4.3 and 4.7 mins respectively. 
6.5.3.2. Assays to determine whether mBBr labelling methods detect HTA  
Excess MG, DHAP and GA3P (10 mM) were reacted with the thiol (Cys, BSH, GSH) (2 mM) 
until complete depletion of residual thiol confirmed by Ellman’s assay. The mBBr 
derivatisation was then carried out on the HTA to confirm whether this technique detects it. 
This process involved reacting 20 μL of bimane mix (50% acetonitrile containing 2 mM mBBr 
and 20 mM HEPES pH 8.0) with 20 μL sample. The procedure was then carried out as 
previously described (chapter 6.5.3.1).  
6.5.3.3. Synthesis and preparation of thiol-mB standards for HPLC 
Ellman’s assay was used to determine the concentration of the thiol. 1 mM stock solutions 
of BSH/Cys were prepared from this which were reacted with mBBr to produce the 
fluorescent thiol-mB adducts as described previously (chapter 6.5.3.1). 20 nmol samples of 
BSH/Cys were then prepared from the stock solution of thiol-mB adducts. 200 μL dilutions 
of methanesulfonic acid (10 mM) were carried out to produce a 500 pmol peak from a 5 μL 
injection on the HPLC.  
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6.5.4. Determination of the reaction order for the forwards and reverse reaction 
Experimental analysis was required to determine the rate orders (equation 6.8-6.10). The 
order of the reaction was determined by investigating the fold-change of the rate of reaction 
when the concentration of a single species is changed. With reference to the reaction 
between MG and Cys (table 6.3), the concentration increases by approximately a factor of 
2. In addition, the initial rate increases by approximately a factor of 2. This therefore 
represents a first order reaction with respect to the Cys concentration (equation 6.11). 
Likewise, for determining the order of reaction with respect to BSH, the concentration 
increases by approximately a factor 3. In addition, the initial rate increases by approximately 
a factor of 3. Therefore, this represents a first order reaction with respect to BSH 
concentration (equation 6.12). With regards to the dissociation of HTA, the determination of 
the order of the reaction was carried out in a similar manner. The concentration increases 
by 2-fold. In addition, the initial rate increases by approximately 2-fold. Therefore, this 
represents a first order reaction (equation 6.13). This sample principle was applied to all 
reactions involved, including thiol reaction with DHAP and GA3P.  
 
Rate = k [Cys]x 
 
Rate = k [BSH]y 
 
Rate = k [HTA]z 
 
Rate = k[Cys]1 
 
Rate = k[BSH]1 
 
Rate = k [HTA]1 
 
 
 
 
 
 
 
 
 
 
Eq. 6.8 
Eq. 6.9 
Eq. 6.10 
Eq. 6.11 
Eq. 6.12 
Eq. 6.13 
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Table 6.3. Reaction order determination for Cys/BSH reaction with three metabolites, MG, DHAP and 
GA3P. 
Experiment [RSH] (μM) [C=O] (μM) Initial rate (μM/s) 
Forwards reactions of Cys + MG – first order reaction 
1a. Cys + MG 166 1500 2.3 
1b. Cys + MG 373 1500 4.3 
Fold change 2.2 1 1.9 
2a. BSH + MG 30 1500 1.8 
2b. BSH + MG 96 1500 4.5 
Fold change 3.2 1 2.5 
Reverse reaction of the dissociation of HTA – first order reaction 
3a. HTA forming Cys and MG 250  0.0015 
3b. HTA forming Cys and MG 500  0.0037 
Fold change 2  2.5 
4a. HTA forming BSH and MG 250  0.0018 
4b. HTA forming BSH and MG 500  0.0030 
Fold change 2  1.7 
Forwards reaction of Cys and DHAP – first order reaction 
5a. Cys + DHAP 782 10000 0.51 
5b. Cys + DHAP 1272 10000 0.77 
Fold change 1.6 1 1.5 
6a. BSH + DHAP 374 10000 0.39 
6b. BSH + DHAP 855 10000 0.72 
Fold change 2.3 1 1.8 
Reverse reaction of the dissociation of HTA – first order reaction 
7a. HTA forming Cys and MG 250  0.0015 
7b HTA forming Cys and MG 500  0.0037 
Fold change 2  2.5 
8a. HTA forming BSH and MG 250  0.0018 
8b. HTA forming BSH and MG 500  0.0030 
Fold change 2  1.7 
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Forwards reaction of Cys and GA3P 
9a. Cys + GA3P 342 10000 0.3883 
9b. Cys + GA3P 804 10000 0.7792 
Fold change 2.4 1 2.0 
10a. BSH + GA3P 353 10000 0.47 
11b. BSH + GA3P 703 10000 0.87 
Fold change 2.0 1 1.9 
Reverse reaction of the dissociation of HTA 
11a. HTA forming Cys and MG 250  0.0031 
11b. HTA forming Cys and MG 500  0.0066 
Fold change 2  2.1 
12a. HTA forming BSH and MG 250  0.0017 
12b. HTA forming BSH and MG 500  0.0035 
Fold change 2  2.1 
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6.6 In vivo experiments 
6.6.1. Media and buffers  
6.6.1.1. B. subtilis strains  
B. subtilis CU1065 WT, B. subtilis CU1065 glxII, B. subtilis CU1065 glxI, B. subtilis CU1065 
glxI/II, B. subtilis and CU1065 bshC were received from Dr Pete Chandrangsu (Cornell 
University, USA).  
6.6.1.2. Growth Media  
B. subtilis was cultured in LB and BM media depending on the experimental choice in the 
appropriate antibiotic as stated in Table 6.4. LB media was made up from 1% bacto-
tryptone, 0.5% yeast extract, 1% NaCl and 2% agar for solid material. BM media was made 
up from basal medium containing 15mM (NH4)2SO4, 8 mM MgSO4, 27 mM KCl, 7 mM 
sodium citrate and 50 mM Tris HCl, pH 7.5. The basal medium was autoclaved before 
adding Tris HCl. Supplements (2 mM KH2PO4, 2 mM CaCl2, 10 μM FeSO4, 10 μM MnSO4, 
4.5 mM glutamic acid, 780 μM tryptophane, 0.2 % glucose) were sterile filtered using a 0.22 
μM Millipore Extra PES membrane filter unit. The supplements were added to the basal 
medium before use. For specific experiments, glucose/arabinose 0.5% were added to the 
BM media which were sterile filtered using a 0.22 μM Millipore Extra PES membrane filter 
unit.  
In the case of agar, after sterilisation it was cooled to temperatures below 50 °C before the 
addition of any specific antibiotics. The agar was poured into the plates and dried at room 
temperature before storage at 4 °C. 
6.6.1.3. Bacterial strain and antibiotics 
All antibiotic stock solutions were prepared 100x concentrated in the specified solvent and 
were filtered 0.22 μM Millipore Extra PES membrane filter unit. The antibiotic stock solutions 
were stored at 4 °C. 
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6.6.2. General maintenance, growth and culturing of bacterial strains  
6.6.2.1. Storage of B. subtilis  
Bacterial strains were grown on LB agar in the appropriate antibiotic(s) (table 6.4) at 37 °C 
overnight and then stored at 4 °C where they were kept for a maximum of 2 weeks. For long 
term storage bacteria strains were kept as glycerol stocks at -80 °C. 
6.6.2.2. Growth and harvesting of bacterial culture  
The appropriate media was inoculated with a single bacterial colony from the specified 
bacterial strain (table 6.5) grown on agar. The bacterial strains were cultured overnight in 
liquid media on the rotator at 37 °C whilst shaken at 200 revolutions per minute (RPM). The 
media was then re-inoculated with 1-1.5% (% v/v) of the overnight culture. The cultures 
were incubated at 37 °C on the rotator at 200 RPM. Growth was measured at regular time 
points by monitoring the optical density at 600 nm (OD600) of 1 mL of cell culture.(74) 
Appropriate dilutions of 1:1 or higher were carried out at an OD600 above 0.9 in order to 
allow photometric measurements in a linear range.  At the appropriate time points, the liquid 
culture was transferred to 50 mL falcon conical centrifuge tubes which were centrifuged for 
5 minutes at 13500 RPM. The supernatant was discarded and the cells were re-suspended 
into pre-weighed eppendorfs. The cells were centrifuged for a further 3 minutes at 13500 
RPM and frozen in liquid nitrogen. They were stored at -30 °C. 
Table 6.4. The antibiotics used in LB agar to confirm the growth of the particular KO. 
 
Table 6.5: Details of the antibiotics and knockout type for each strain of B. subtilis. 
 
 
Antibiotic Final concentration (µg/mL) Solvent for stock solution 
Chloramphenicol 5 EtOH 
Kanamycin 10 Water 
Spectinomycin 100 Water 
Erythromycin 1 EtOH 
Lincomycin 25 Water 
Strain Knock-out Antibiotic 
CU1065 WT - 
HB11069 CU1065 glxII::kan Kanamycin 
HB11079 CU1065 bshC::kan Kanamycin 
HB16505 CU1065 glxI::cm Chloramphenicol 
HB16545 CU1065 glxI::cm glxII::kan Chloramphenicol, Kanamycin 
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6.6.3. In vivo experiments for the analysis of MG and LMW thiol content 
6.6.3.1. Preparation, harvesting and thawing of B. subtilis cells 
Overnight cultures were prepared by the inoculation of a single colony of bacterial cells from 
agar plates, incubated on the rotator at 37 °C shaken at 200 RPM. A 1 - 1.5% re-inoculation 
of the overnight culture was carried out. At the appropriate time point, depending on the 
OD600 of B. subtilis growth, the liquid culture corresponding to approximately 10 mg RDW 
was transferred into 50 mL falcon conical centrifuge tubes and centrifuged for 5 minutes at 
13500 RPM. Supernatant was discarded and the cell pellet was re-suspended in media into 
pre-weighed 1.5 mL eppendorf microcentrifuge tubes. The samples were centrifuged again 
for 3 minutes at 13500 RPM. The cells were harvested and remaining supernatant was 
discarded. The samples were frozen under liquid nitrogen and stored at -30 °C. This 
process was carried out at 40-minute intervals covering all phases of the bacterial growth 
curve. 
6.6.3.2. Calculated residual dry cell weights for thiol analysis  
Cells were harvested at various different OD600 and therefore required different volumes of 
liquid culture to produce 10mg residual dry cell weight (RDW) required for mBBr thiol 
analysis and other techniques. A standardisation curve was produced; y = 0.224 x + 0.089, 
where the required volume of liquid culture was calculated to produce 10 mg RDW based 
on the specific OD600. In B. subtilis, there is an equal ratio of RDW to intracellular water. 
Therefore, as an example, 0.2 μmol/g equates to 0.2 mM when the data is represented as 
a concentration.(20) 
6.6.3.3. Growth comparisons of LB media and BM media 
Bacillus subtilis WT CU1065 strain was used for growth, mBBr thiol analysis and the MG 
derivatization experiments. The bacterial strains were cultured overnight in LB media on the 
rotator at 37 °C. Two experiments were carried out in parallel containing LB media and BM 
media both inoculated with 1 – 1.5 % of the overnight culture. The cultures were incubated 
at 37 °C and put on the rotator at 200 RPM. OD600 readings were carried out at equal time 
intervals throughout the bacterial growth cycle to assess response and growth of B. subtilis 
to the different conditions.  
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6.6.3.4. Determination of thiol content using mBBr thiol analysis  
MBBr derivatisation was carried out on all B. subtilis strains listed on table 6.5. This process 
was used to fluorescently label thiols to be detected via HPLC.(162) 20 μl of bimane mix (50% 
acetonitrile containing 2 mM mBBr and 20 mM HEPES, pH 8.0) were added per mg of 
estimated dry residual weight. The procedure was carried out as described previously 
(chapter 6.5.3.1). 
6.6.3.5. Determination of extracellular MG levels using 2,4-dinitrophenyhydrazine 
(2,4-DNPH)  
The extracellular MG concentration was determined in all B. subtilis strains listed on table 
6.5. 2,4-Dinitrophenylhydrazine (2,4-DNPH) was used as the derivatising agent (chapter 
6.4.2. scheme 6.3) used to qualitatively test for carbonyl groups. It reacts with the ketones 
and aldehyde of MG to produce 2,4-dinitrophenyhydrazone which can then be measured 
spectrophotometrically at 432 nm.  
Initially cells were cultured in LB media, however 2,4-DNPH was found to react with LB 
media producing a negative gradient; y= -0.5404x. 2,4-DNPH was more stable in BM media, 
showing no reactivity and therefore the media of choice. BM media was inoculated with B. 
subtilis and grown as discussed previously. At an OD600 of 0.7, 1 mM of MG was added to 
the B. subtilis culture with the two additional controls; BM media with 1 mM MG, and B. 
subtilis alone. 
A 2 mM stock solution of 2,4-DNPH was prepared in ethanol which was diluted 10-fold in 
12 % HCl in ethanol.(155) At the appropriate 40-minute intervals, 0.2 mM 2,4-DNPH was 
reacted with the MG incubated B. subtilis culture for 45 minutes at 42 °C. Samples were 
then incubated at room temperature for 5 minutes. Spectrophotometer measurements were 
carried out at 432 nm. The concentrations were determined by comparison to a 
standardisation curve. This was prepared by reacting 0.2 mM 2,4-DNPH with 10 different 
MG concentrations ranging from 0 μM to 125 μM in vitro. A standardisation curve was 
prepared for every new supply of MG and 2,4-DNPH solution due to the varying 
concentrations in each stock.  
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6.6.3.6. Determination of extracellular MG in the presence of glucose/arabinose 
0.5% 
The extracellular MG concentration was determined in B. subtilis WT and bshC mutant 
strain in the presence and absence of glucose/arabinose 0.5%. BM media was 
supplemented with 0.5 % glucose/arabinose and the B subtilis KO were grown over 72 
hours to achieve the full bacterial growth curve. At ~3 hour intervals, the cells were 
harvested and MG was quantified to determine the extracellular concentrations of MG as 
previously described.  
6.6.3.7. Effect of B. subtilis WT and bshC mutant growth upon variable MG stress 
B. subtilis WT and bshC mutant strain were re-inoculated from an overnight culture and 
grown on the rotator at 37 °C shaken at 200 RPM. At an OD600 of 0.7, variable 
concentrations of MG were added to the liquid culture including 0 mM, 1 mM, 2 mM, 5 mM 
and 10 mM. OD600 results were taken at hourly intervals over the first 3 hours to determine 
the effect that MG has on the growth of cells.  
6.6.4. In vivo experiments for the analysis of glycolytic metabolites and LMW thiols 
content 
6.6.4.1. Growth of B. subtilis in preparation for intracellular DHAP quantification   
LB media was inoculated with a single bacterial colony from the specified bacterial strain 
grown on agar. The bacterial strains were cultured overnight in liquid media on the rotator 
at 37 °C whilst shaken at 200 RPM. 1000 mL LB media was then re-inoculated with 1-1.5% 
(% v/v) of the overnight culture. The cultures were incubated at 37 °C on the rotator at 200 
RPM. At early-, mid- and late-exponential phase, the culture was transferred to falcon tubes 
and centrifuged as previously described. Due to the sensitivity limits of the DHAP assay, an 
estimated 50 mg RDW of B. subtilis cells was collected for each sample. The cells were 
immediately frozen in liquid nitrogen and stored at -30 °C. 
6.6.4.2. Intracellular DHAP quantification  
The intracellular DHAP concentration was determined at different stages of the B. subtilis 
growth. Many techniques were carried out to lyse the cells, which included acidification, 
freeze thawing and bead beating.(163, 164) Reported literature on lysing cells via acidification 
proved to be successful in some instances however regulating the pH proved to be difficult 
and therefore consistent results could not be reproduced in the experiments.(164) 
Lysing the cell by bead beating with zirconium 0.1 mm beads proved the most successful. 
Samples containing an estimated 50 mg B.subtilis WT RDW were left at room temperature 
to thaw for 5 minutes. 300 µL of 50 mM HEPES buffer, pH 7.7, and 250 mg 0.1 mm 
zirconium beads (purchased from Sigma) were added to the cells. The samples were placed 
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on the disruptor genie for 1-minute intervals and then cooled on ice. This was repeated 5 
times. The cells were then heated to 80 °C to denature enzymes and the cells were 
centrifuged for 10 minutes at 13000 RPM. The supernatant was then transferred to Amicon 
ultra-0.5 mL centrifugal filters and centrifuged for 30 minutes at 13000 RPM. The remaining 
dry cells were placed in the oven. 20 µl of 50 mM HEPES buffer, pH 7.7, was added to the 
supernatant and centrifuged for a further 10 minutes at 13000 RPM to ensure all molecules 
below 3000 MW had passed through the membrane. The DHAP assay as described earlier 
was carried out on the filtered supernatant (chapter 6.5.2.1). So, the concentration of 
intracellular DHAP was determined by measuring the depletion of NADH to NAD+ to 
produce G3P catalysed by G3PD. The assay was carried out in a reaction mixture 
containing 134 mM HEPES and filtered supernatant. The addition of 0.13 mM NADH 
corresponded to a ~ 0.7 A. Controls were carried out for background absorbance by 
monitoring absorbance change over 5 minutes prior to adding NADH and after adding 
NADH. The reaction was started by the addition of 1 U G3PD enzyme and monitored NADH 
consumptions to NAD+ at 340nm for 5 minutes on the UV-vis spectrophotometer.  
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6.7. Metabolomics studies   
6.7.1. Mass spectrometric studies 
Mass spectrometric samples, run on the Shimadzu ion-trap ToF mass spectrometer were 
run by Dr Lionel Hill (John Innes Centre, Norwich). The six potential HTAs including DHAP-
Cys, GA3P-Cys, MG-Cys, DHAP-SB, GA3P-SB and MG-SB were analysed. The 5 mM 
concentration of the product was diluted 10-fold in 50% MeOH. The spectrometer was 
prepared and spectra were collected from m/z 200-2000 with a maximum ion accumulation 
time of 20 ms, and automatic sensitivity control set to a target of 70% optimal base peak 
intensity. For MG-Cys, the mass range was m/z 160-2000. The instrument also collected 
data-dependent MS2 of the most abundant precursor ions. MS2 was carried out at 50% 
collision energy, 50% collision gas, with an isolation window of 3Da, and an ion 
accumulation time fixed at 20 ms. Spectra were collected down to m/z 50. Spray chamber 
conditions were 250 °C curved desorption line, 300 °C heat-block, 1.5 L.min-1 nebuliser gas, 
and drying gas “on”. The instrument was calibrated using sodium trifluoroacetate cluster 
ions. 
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6.7.2. In vitro NMR studies  
6.7.2.1. Preparation of stock and buffer solutions 
1 M stock solutions of Cys, DHAP, acetone and MG were prepared in D2O. 2 M sodium 
phosphate buffer and 2 M HEPES buffer, pH 7.7, were prepared in water and pH 
calibrated.(165) The buffers were freeze-dried overnight and then prepared in D2O ensuring 
no residual H2O traces to produce 2 M sodium phosphate buffer and 2 M HEPES buffer, 
~pD 8.1. 
6.7.2.2. In vitro NMR assays  
Acetone and MG were reacted with thiols in determination of HTA for NMR analysis: 
1) A 2:1 ratio of acetone (200 mM) to Cys (100 mM) was prepared in sodium phosphate 
buffer (200 mM, pD 8.1) in D2O. 
 
2) A 1:1 ratio of MG (10 mM) to thiol (10 mM) was prepared in sodium phosphate buffer 
(50 mM, pD 8.1) in D2O. The experimental process was carried out by Dr Sunil 
Sharma. 
All NMR analysis consisted of  1H NMR, 13C NMR, heteronuclear single quantum coherence 
(HSQC) and heteronuclear multi-bond correlation (HMBC) analysis, which were performed 
on the Bruker 500 MHz spectrometer for acetone and the Bruker 400 MHz spectrometer for 
MG analysis.  
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6.7.3. Whole cell NMR analysis 
6.7.3.1. Cell culturing 
Whole cell NMR analysis was carried out by Francesc Puig. B. subtilis CU1065 (WT) strain 
and CU1065 (glxI mutant) strain was used for the whole cell NMR analysis. The bacterial 
strains were cultured overnight in LB media on the rotator at 37 °C at 200 RPM. A 2% 
inoculation of the overnight culture in 50 mL sulfur-free minimal media supplemented with 
each non-labelled and 13C-labelled Cys (1 mM), which were grown to an OD600 of 0.4. 25 
mL of the culture was incubated with MG (1 mM) for a further 30 minutes before the cells 
were harvested. The appropriate control of no MG was carried out in parallel. Cells were 
harvested by centrifuging at 5000 RPM for 3 min at 4ºC, which were washed with 200 μL of 
25 mM deuterated phosphate buffer saline. Samples were frozen in liquid nitrogen and 
stored at -80ºC. 
6.7.3.2. Media preparation 
The sulfur-free minimal media was made up from basal medium containing 6 mM K2HPO4, 
4.4 mM KH2PO4, 4 mM MgCl2. 250 μM CaCl2 and 10 μM MnCl2. The basal medium was 
autoclaved before adding the supplements, 0.5 % D-glucose, 50 mM L-Tryptophan, 0.1% L-
glutamine, 11 mM ferric ammonium citrate and 0.3 mM trisodium citrate. The supplements 
were sterile filtered using a 0.22 μM Millipore Extra PES membrane filter unit. 
6.7.3.3. NMR analysis 
Samples were thawed on ice and resuspended in 400 μL deuterated PBS. A coaxial insert 
containing 1 mM NMR standard DSS in D2O. 1H, 13C and HSQC NMR analysis was carried 
out on the sample regulated at 5 °C. 
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Table 6.6. 1H and 13C NMR chemical shifts in acetone, Cys and Cys-acetone HTA. 
Moiety   δH 500 MHz δC 100 MHz 
  Free ligand HTA Free ligand HTA 
Free Cys 
 
 
 
 
 
HTA 
 
1 
 
 
 
2 
 
 
 
3 
- 
 
 
 
3.89 
1H, dd 
J=4 Hz 
 
3.01, 2.95 
2H, 2dd 
J=5.5, 4 Hz 
 
- 
 
 
 
3.87 
1H, dd 
J=4 Hz 
 
2.93, 3.38  
2H, 2dd 
J=9, 7 Hz 
 
172.9 
 
 
 
55.8 
 
 
 
25.1 
177.5 
 
 
 
66.4 
 
 
 
39.1 
Acetone 
 
 
 
 
HTA 
4 
 
 
 
5 
 
 
 
6 
2.13 
3H, s 
 
 
- 
 
 
 
2.13  
3H, s  
1.61 
3H, s 
 
 
- 
 
 
 
1.43 
3H, s 
30.1 
 
 
 
215.4 
 
 
 
30.1  
 
28.8 
 
 
 
74.8 
 
 
 
30.8 
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Table 6.7. 1H and 13C NMR chemical shifts of Cys, MG and Cys-MG HTA. 
 
 
 
 
 
 
 
 
 
Moiety   δH 500 MHz δC 100 MHz 
  Free  
ligand 
HTA (A) HTA (B) 
 
Free 
ligand 
HTA  (A) HTA (B) 
 
Free Cys 
 
HTA 
 
1 
 
2 
 
 
 
 
 
 
3 
- 
 
3.84 
1H dd 
J=6.8 Hz 
 
 
 
 
2.96, 2.90 
2H, 2dd 
J= 5 Hz 
 
- 
 
3.89 
1H t 
J = 8.5 Hz 
 
 
 
 
2.62 t 
J= 10.4 Hz 
3.23 dd  
J=6 2H 
 
 
3.70,  
1H dd 
J=6 Hz 
 
 
 
 
2.88 dd 
J=6.4, 6.8 Hz 
3.11 dd 
J=6.8, 7.2 Hz 
 
 
172.9a 
 
55.8a 
 
 
 
 
 
 
25.1a 
177.6 
 
69.0 
 
 
 
 
 
 
37.3 
 
176.6 
 
67.2 
 
 
 
 
 
 
37.0 
Methylglyoxal 
 
HTA 
 
4 
 
 
5 
 
 
6 
8.97c, s 
 
 
- 
 
 
2.22c, s 
5.35, s,  
 
 
- 
 
 
2.24, s, 3H 
5.10, s, 
 
 
- 
 
 
2.15, s, 3H 
 
188.8a 
 
 
197.3a  
 
 
22.9a 
57.30 
 
 
- 
 
 
27.1 
 
64.2 
 
 
 
 
 
25.7 
a) No signals were determined in control experiments and therefore literature reactions are shown, in D2O(166) 
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Table 6.7.1H and 13C NMR chemical shifts in MG, BSH and BS-MG HTA. 
 
 
 
 
 
 
 
 
References  
Moiety   δH 500 MHz δC 100 MHz 
  Free ligand HTAa Free ligand HTAa 
Free BSH 
  
HTA 
 
1 
 
 
 
2 
 
 
 
3 
- 
 
 
 
3.9b m 
 
 
 
3.07b m 
 
- 
 
 
 
4.06b m 
 
 
 
2.69b m 
 
167.2 
 
 
 
53.9 
 
 
 
24.7 
- 
 
 
 
61.4  
 
 
 
37.6 
Methylglyoxald 
 
HTA 
 
4 
 
 
 
5 
 
 
 
6 
8.97c m 
 
 
 
- 
 
 
 
2.21b m 
 
 
 
 
 
- 
 
 
 
2.25b m 
 
 
188.8c 
 
 
 
197.3c 
 
 
 
25.0c 
 
 
174.5 
 
 
 
- 
 
 
 
27.1 
 
a) The diastereomers of the HTA were not detected 
b) Overlapping of peaks on 1H NMR means the splitting is not interpretable  
c) No signals were determined in control experiments and therefore literature reactions are shown in D2O(166) 
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